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Abstract
In supraventricular tissues adenosine decreases spontaneous pacemaker activity
(negative chronotropy), atrioventricular nodal conduction (negative dromotropy) and
myocardium contraction force (negative inotropy) through the activation of adenosine A1
receptor (A1R) (Headrick et al., 2011). A1R is a Gαi/o-protein coupled receptor. Once
activated, A1R may inhibits catecholamine-stimulated adenylyl cyclase (anti-β-adrenergic
effect), increases hyperpolarizing K+ currents carried through GIRK/KIR3 channels
(Belardinelli et al., 1995) and stimulates phospholipase Cβ activity and PKC translocation
(Parsons et al., 2000; Yang et al., 2009b). Preliminary data from our lab showed that
adenosine is a “chronoselective” atrial depressant via the activation of A1R, yet this
property is not shared by other cardiodepressant agents, like acetylcholine acting through
muscarinic M2 receptor (M2R) activation (Oliveira-Monteiro et al., unpublished
observations). The mechanism(s) underlying adenosine “chronoselectivity” remains to be
identified. Given their involvement in atrial physiology, we sought it would be interesting to
investigate the expression and function of subtype-selective K+ and Ca2+ channels in the
spontaneously beating rat atria. The putative enrolment of PLC/PKC signaling pathway on
A1R chronoselectivity was also investigated.
Both the A1R agonist, R-PIA (0.001–1 µM), and the muscarinic M2 receptor
agonist, oxotremorine (0.01–3 µM), decreased in a concentration-dependent manner the
rate (negative chronotropic effect) and the strength of contractions (negative inotropic
effect) in the spontaneously beating rat atria. Unlike muscarinic M2 receptor activation with
oxotremorine, the A1 receptor-mediated negative chronotropic effect of R-PIA was
evidenced at much lower concentrations than its negative inotropic action
(chronoselective effect). The effects of oxotremorine and of R-PIA were prevented upon
blocking M2Rs with AF-DX 116 (10 µM) and A1Rs with DPCPX (100 nM), respectively.
Blockade of GIRK/KIR3 channels with tertiapin Q (300 nM) prevented negative
chronotropism and inotropism of both A1 and M2 receptor agonists, respectively R-PIA and
oxotremorine. Inhibition of Kv and KATP/KIR6 currents, respectively with 4-aminopyridine
and glibenclamide, were devoid of effect. Blockade of KCa2/SK channels with apamin and
CaV1 (L-type) channels with verapamil, sensitized atria to the negative inotropic action of
R-PIA, without affecting the nucleoside chronotropic effect and the oxotremorine effect.
The same occurred when rat atria were pre-treated with PLC and PKC inhibitors, such as
U73122 (3 µM) and chelerythrine (3 µM), respectively. Immunolocalization studies
showed that differences in the distribution of A1 receptors between the sinoatrial node and
surrounding cardiomyocytes might not afford a rationale for adenosine chronoselectivity.
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Immunolabeling of KIR3.1, KCa2.2, KCa2.3 and Cav1 was also observed throughout the right
atria.
Functional data support Gβγ/PLC/PKC signaling axis as an important pathway to
counteract the negative inotropic effects of GIRK/KIR3 opening following A1R stimulation.
After GIRK/KIR3 activation, Gβγ subunits released from the vicinity of A1R may negatively
regulate these channels through PIP2 hydrolysis. Decrease of K+ current carried by
GIRK/KIR3 channel along with lower KCa2/SK channel conductance embrace a
compensatory mechanism for A1R, which is not present with M2R activation. As CaV1 (L-
type) channel blockade sensitized atria to contractile depression promoted via Ca2+ influx,
these channels connect inhibition of hyperpolarizing K+ currents to greater time available
for Ca2+ influx. This study strengthens the differences between A1R and M2R signaling in
the heart, particularly with respect to PLC/PKC modulation, providing new insights into
adenosine’s chronoselectivity.
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Resumo
Em tecidos supraventriculares a adenosina diminui a atividade marcapasso das
células do nó sinusal (cronotropismo negativo), a condução auriculoventricular
(dromotropismo negativo) e também a força contrátil do miocárdio (inotropismo negativo),
sendo estes efeitos mediados pela ativação do recetor da adenosina do subtipo A1
(Headrick et al., 2011). O recetor A1 é um recetor acoplado a proteínas Gαi/o cuja
estimulação despoleta a ativação de várias vias de sinalização, incluindo: inibição da
ciclase do adenilato estimulada por catecolaminas (efeito anti-β-adrenérgico);
hiperpolarização da membrana dos cardiomiócitos, em consequência da abertura de
canais GIRK/KIR3 (Belardinelli et al., 1995); estimulação da fosfolipase Cβ e,
consequente, translocação da PKC (Parsons et al., 2000; Yang et al., 2009b). Em
estudos anteriores realizados no nosso laboratório verificou-se que a adenosina, atuando
em recetores A1, apresenta-se como agente depressor auricular com propriedades
“crono-seletivas” singulares, não compartilhadas por outros agentes cardiodepressores,
tal como a estimulação de recetores muscarínicos sensíveis à ACh do subtipo M2
(Oliveira-Monteiro et al., observações não publicadas). Até ao momento os mecanismos
responsáveis pelas propriedades crono-seletivas deste nucleósido não são perfeitamente
conhecidos. Dada a importância da função auricular na fisiologia cardíaca, propusemo-
nos estudar a função e a expressão de determinados subtipos de canais de K+ e Ca2+ em
aurículas isoladas de ratazana a contrair espontaneamente, sendo também avaliado o
hipotético envolvimento da via da PLC/PKC na crono-seletividade mediada pela ativação
dos recetores A1.
Tanto a R-PIA (0.001-1 µM), um agonista seletivo A1, como a oxotremorina (0.01-
3 µM), um agonista do recetores muscarínico M2, diminuíram de uma forma dependente
da concentração a frequência (efeito cronotrópico negativo) e força de contração (efeito
inotrópico negativo) em aurículas de ratazana a contrair espontaneamente.
Contrariamente ao observado na ativação de recetores M2 sensíveis à oxotremorina, os
efeitos cronotrópicos negativos resultantes da ativação A1 foram observados a
concentrações de agonista muito inferiores às necessárias para produzir uma redução
significativa da força contrátil (efeito “crono-seletivo”). Os efeitos da oxotremorina e da R-
PIA foram prevenidos após o bloqueio dos recetores M2 (AF-DX 116; 10 µM) e A1
(DPCPX; 100 nM), respetivamente. O bloqueio dos canais GIRK/KIR3 com tertiapina Q
(300 nM) preveniu os efeitos cronotrópico e inotrópico negativos mediados pelos
agonistas dos recetores A1 (R-PIA) e M2 (oxotremorina). A inibição dos canais Kv e
KATP/KIR6 com 4-AP e glibenclamida, respetivamente, não produziu qualquer efeito nas
respostas resultantes da estimulação A1 e M2. Por outro lado, o bloqueio dos canais
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KCa2/SK com apamina, assim como o bloqueio dos canais CaV1 do tipo L com verapamil,
sensibilizaram o tecido auricular para as respostas inotrópicas negativas da R-PIA, não
afetando a resposta cronotrópica produzida por este agonista, nem as respostas
produzidas pela oxotremorina. Resposta similar foi observada após a inibição da PLC
(U73122; 3 µM) e da PKC (cheleritrina; 3 µM). Estudos de imunolocalização por
microscopia confocal demonstraram uma distribuição homogénea dos recetores A1 da
adenosina entre o nó sinusal e o músculo auricular circundante e, como tal, a crono-
seletividade observada não ter como base a expressão diferencial deste recetor no tecido
supraventricular. Observou-se ainda que os canais KIR3.1, KCa2.2, KCa2.3 e Cav1 se
encontravam presentes em todo o tecido auricular.
Em suma, os dados funcionais deste trabalho demonstram que o eixo formado
pelas subunidades Gβγ, PLC e PKC representam uma importante via de sinalização dos
recetores A1, que contrapõe os efeitos inotrópicos negativos decorrentes da abertura de
canais GIRK/KIR3. Após a abertura de canais GIRK/KIR3, as subunidades Gβγ libertadas
após a ativação A1 poderão também regular negativamente a condutância deste mesmo
canal, através da promoção da hidrólise de PIP2 por via da estimulação da PLC. A
diminuição das correntes hiperpolarizantes GIRK/KIR3, conjuntamente com uma menor
condutância iónica por parte dos canais KCa2/SK, poderão representar um mecanismo
compensatório intrínseco dos recetores A1 que, aparentemente, não se encontra presente
na sinalização dos recetores M2. Como o bloqueio de canais de CaV1 (tipo-L) sensibilizou
as aurículas para a depressão contrátil, é possível que a inibição das correntes
hiperpolarizantes de K+ possa aumentar o tempo disponível para o influxo de Ca2+. Este
estudo reforça ainda as diferenças funcionais existentes entre os recetores A1 e M2,
particularmente no que diz respeito à modulação da PLC/PKC, fornecendo novas pistas
para a crono-seletividade da adenosina.
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I. Introduction
Every day the heart muscle rhythmically contracts and relaxes thousand times in
order to ensure the correct perfusion of all body organs and tissues.The cardiac cycle
produces pressure changes within the cardiovascular system allowing blood movement
from higher pressure regions to lower ones. Low pressure blood flowing through vena
cava (systemic circulation) and pulmonary veins (pulmonary circulation) firstly fills atrial
chambers (right and left, respectively) and then the corresponding ventricles. Inside right
and left ventricles blood is pressurized by heart muscle contraction (systole) providing
enough energy to overcome the vascular resistance to blood flow through arterial blood
vessels of pulmonary and systemic circulation, respectively. Following contraction, the
heart muscle undergoes a relaxation period (diastole) that ends cardiac cycle. Cardiac
cycle is a sequence of mechanical events timely ordered by heart’s first pacemaker – the
sinoatrial node (SA node). Here, spontaneous and rhythmical impulses are generated and
conducted over the whole heart through its electrical wiring system (SA node,
atrioventricular node, His bundle). The myogenic nature of cardiac action potentials (APs)
explains why a denervated heart still maintains spontaneous contractions (Kurachi et al.,
2000).
The heart is endowed with a “little brain” that integrates signals and coordinates
cardiovascular responses, reacting to instantaneous body needs by means of cardiac
output and arterial pressure adjustment. Heart function is under the control of the
autonomic nervous system that innervates several key structures of the heart, such as the
SA node and the myocardium. The “flight-or-fight response” activates sympathetic efferent
fibers and stimulates norepinephrine (NE) release from sympathetic varicosities that
mostly binds to β1-adrenoceptors (β1-AR) thus increasing heart rate (positive chronotropy),
contractility (positive inotropy) and impulse conduction speed (positive dromotropy). On
the other side, acetylcholine (ACh) released from parasympathetic (vagal) efferents binds
to M2 muscarinic ACh receptors (M2R) and refrains catecholamine-stimulated cardiac
output (negative chronotropy, inotropy and dromotropy). ACh effects are almost
exclusively orchestrated through inhibitory M2R, which is by far the most expressed
muscarinic receptor in the mammalian heart (Krejci and Tucek, 2002). The other non-M2
muscarinic receptors are expressed at low abundance, despite no conclusive data about
the relative expression of each receptor in atria and ventricles (Krejci and Tucek, 2002;
Myslivecek et al., 2008).
M2R and β1-AR comprise two important families of G-protein coupled receptors
(GPCRs) in what heart regulation concerns. GPCRs are single polypeptide chains that
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span the cellular membrane seven times and bind to GTP binding proteins (also known as
G-protein). G-proteins are guanine-nucleotide regulatory heterotrimeric protein complexes
of Gα, Gβ, and Gγ subunits with a remarkable variety of physiological actions on numerous
effectors, such as protein kinases, phosphodiesterases, phospholipases, transcription
factors, intracellular receptors and ion channels (Milligan and Kostenis, 2006). Although
chaotic at first glance, GPCRs signaling partners are organized and compartmentalized in
membrane microdomains providing fidelity, speed and graded responses to GPCR
agonists (Patel et al., 2008).
In resting conditions, the heart is predominantly under the tonic influence of the
parasympathetic system. Autonomic nerves and other neurohormonal mechanisms
control the cardiac output by changing either the stroke volume or the heart rate. Heart
rate is set by SA node activity whereas ventricular stroke volume is regulated by multiple
mechanisms, including preload, afterload and muscle inotropy. Even though stroke
volume is much more dependent on the mechanical properties of ventricular myocardium,
atria have also an important role on stroke volume regulation, particularly during cardiac
sympathetic drive (e.g. physical activity) or myocardial dysfunction (Kurachi et al., 2000).
Supporting the functional relevance of atria, some supraventricular arrhythmias (e.g.
supraventricular tachycardia, atrial fibrillation) withdraw the contribution of atrial
contraction to ventricular filling. This compromise of ventricular filling together with the
rapid ventricular rate associated to these arrhythmias could lead to hemodynamic
perturbations (Samet, 1973). Abnormalities in impulse initiation and conduction are the
main arrhythmogenic mechanisms. Fortunately, there are some clinical approaches
available to reverse these cardiac rhythm abnormalities, such as carotid sinus massage,
catheter ablation and anti-arrhythmic drug therapy (e.g. adenosine [ADO]) (Blomstrom-
Lundqvist et al., 2003). Heart function impairment compromises the correct perfusion of all
tissues and organs; consequently, the fundamental physiological processes that ensure
the correct body homeostasis are compromised.
1. The heart’s first pacemaker – the sinoatrial node
Heart contraction is primarily triggered at the SA node. This outstanding structure
remained unknown for many years, until the seminal work of Arthur Keith and Martin Flack
(Keith and Flack, 1907). The SA node has a complex and heterogeneous structure of non-
contractile cardiac myocytes located within the right atria boundary with the superior vena
cava (intercaval region) and extending to the inferior vena cava in most mammals (Boyett
et al., 2000) (Figure 1). Within this interface, the SA node is surrounded by epicardic and
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endocardic layers, and it is just a thin layer that nearly occupies the entire atrial wall
thickness (Anderson and Ho, 1998; Boyett et al., 2000; Monfredi et al., 2010). While in
some mammals the SA node is too small to be seen without at least magnifying lens, as it
happens with small mammals (e.g. rat, guinea pig), the human’s SA node can be seen
with the naked eye. Therefore, the precise location of the SA node of experimental animal
models (e.g. rat) often requires identification of either anatomical or molecular markers.
Histological sections allow us to identify some of the anatomical markers of the SA node.
The Masson’s trichrome staining is usually used for the histological identification of the SA
node because SA nodal cells are inserted in a collagen matrix, rich in elastic fibers
randomly orientated, and surrounded by atrial muscle, exhibiting bluish and reddish tones,
respectively. The abundance of connective tissue serves as an important insulating matrix
from the neighborhood hyperpolarizing currents of surrounding atrial muscle (Boyett et al.,
2000; Monfredi et al., 2010).
The adult human’s SA node is located under the epicardic surface of the crista
terminalis where a subepicardic large artery - the sinus node artery – is usually visible
(Anderson and Ho, 1998). The architecture of the SA node and its surrounding area is
species dependent (Boyett et al., 2000). In some animals it is possible to identify particular
areas of the right atrial appendage such as: SA node center, paranodal area and crista
terminalis. The terminal crest is a thick atrial muscle that comprises high density of large
cardiomyocytes disposed in a longitudinal rearrangement (Dobrzynski et al., 2005).
Cardiomyocytes from crista terminalis (atrial muscle) are densely packed, whereas SA
node center is a meshwork of SA nodal cells, randomly distributed throughout an
extracellular matrix of connective tissue. The paradonal area lies between the atrial
muscle and SA node and it has a poor organized mixture of nodal and atrial-like cells,
located near the SA node (Chandler et al., 2009; Monfredi et al., 2010). As we move
towards the periphery of the SA node, the structural and electrophysiological properties of
the atrial tissue modify itself (Figure 1). For example, cells from the SA node center have
roughly a smaller diameter than cells from its periphery, and even smaller compared with
atrial muscle cells (Dobrzynski et al., 2005; Allah et al., 2011).
In some mammals, SA nodal cells can be classified as “pale” cells, according to its
morphological characteristics. “Pale” cells are round-shaped cells with an evident nucleus
and long cytoplasmatic extensions along with poorly developed sarcomeres and
sarcoplasmic reticulum (SRs) that give them an empty look (James et al., 1966). They are
generally found in clusters with few intercellular junctions, whose function is primarily to
generate APs and, therefore, they are considered the true pacemaker cells (James et al.,
1966; Monfredi et al., 2010). Notwithstanding, the morphological identification of SA node
cells is not so straightforward, since it has been found within the SA node cells with
ICBAS/FCUP
Introduction 4
various sizes, morphologies (e.g. elongated spindle, spindle and spider cells) and
electrical properties (Boyett et al., 2000) (Figure 1). Toward the periphery are found
“transitional cells” that are elongated and exhibit a transition phenotype, or a mixture of
different cells, or even both, between the “pale” cells and the myocytes from working
myocardium (James et al., 1966; Boyett et al., 2000; Balbi et al., 2011). In fact, as we get
closer to the atrial muscle, the density, organization and size of myocyte-like cells raise up
and the atrial tissue becomes more specialized for contraction and electric impulse
conduction than for spontaneous impulse generation (Boyett et al., 2000; Dobrzynski et
al., 2005; Allah et al., 2011) (Figure 1). Other cells have also been described in the SA
node, such as adipocytes, present in the periphery of the SA node from adult mammals
(Melo et al., 2001), and “fibroblast-like cells” that are immersed in the loose collagen
matrix of the SA node (Dobrzynski et al., 2005; Balbi et al., 2011).
Apart from anatomical markers, this specialized heart structure can be identified by
several molecular markers. The discovery of molecular markers of the SA node is highly
related to its unique cellular features. Molecular markers are based on the differential
expression pattern of some ion channels throughout the atria, which include calcium
(Ca2+), potassium (K+), sodium (Na+) channels and other proteins (Chandler et al., 2009).
However, it should be noted that, in some experimental models, the molecular markers of
the SA node could not be the same between animals from different species and they
could even change during animal’s development (Boyett et al., 2000; Allah et al., 2011).
The SA node exhibits low abundance of atrial natriuretic peptide and gap junction
connexin 43 (Cx43), while the opposite is true for the atrial muscle (Chandler et al., 2009).
The paranodal area exhibits a mixed phenotype, with cells expressing either proteins or
none of them (Chandler et al., 2009; Monfredi et al., 2010). Low Cx43 expression among
other connexins reinforce the poor electrical coupling provided by higher amounts of
connective tissue within the SA node (Dobrzynski et al., 2005). The middle (160/165-kDa)
neurofilament (NF160) is a positive marker of the SA nodal area that is nearly absent in
the atrial muscle (Dobrzynski et al., 2005). Since SA node possesses pacemaker cells,
the expression of ion channels responsible for the pacemaker or “funny” current (If) (see
above) may also be used as marker of the SA nodal area (Chandler et al., 2009). L-type
calcium channel (CaV1) subtypes expression can also be regarded as molecular markers
of atrial areas. The number of putative markers for each atrial area is huge and these are
listed in numerous articles (Tellez et al., 2006; Chandler et al., 2009; Allah et al., 2011;
Yanni et al., 2011), strengthening the concept of an incredible heterogeneous and
complex tri-dimensional structure of the right atrium (Boyett et al., 2000; Dobrzynski et al.,
2005).
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Figure 1. The mammalian heart and the electrophysiologic heterogeneity of the right atrium. In the center of figure is a
schematic representation of mammalian heart (aorta (Ao); pulmonary artery and vein (PA and PV, respectively); coronary
sinus (CS); superior and inferior vena cava (SVC and IVC, respectively); right atrium (RA) and right ventricle (RV)). The
central (leading pacemaker site) and peripheral area of the SA node are red and blue labeled, respectively. Inside the three
boxes are depicted the most important outward and inward currents that shape action potentials from central (red box) and
peripheral (blue box) SA node cells, and from atrial myocytes (black box). Resting (4*); diastolic depolarization (4); upstroke
(0); early repolarization (1); plateau (2) and final repolarization (3) are the phases of the action potentials. The ionic currents
depicted show the time course and direction (e.g. inward if below the line) of the ionic currents. Currents: sodium current
(INa); slow and fast delayed rectifier (IK); T-type calcium current (ICa,T); L-type calcium current (ICa,L); slow inward rectifier
current (IK1); funny current (If); Na+/Ca2+ exchanger; transient outward current (Ito). Adapted from (Dobrzynski et al., 2005)
and (Park and Fishman, 2011).
The generated pacemaker AP has enough power to excite neighboring cells
around the SA node center, driving the electrical impulse through the heart conduction
system. The SA node center is not entirely electrically-insulated and, from the SA node
center toward periphery, bundles of heterogeneous cellular population (a mixture of atrial
and SA node cells) arise and break crista terminalis toward the remaining atrial muscle.
These cellular bundles ensure a physical connection between SA node center and its
periphery, while it also shields the SA node from the interfering currents generated
peripherally (Oosthoek et al., 1993; Dobrzynski et al., 2005). Thus, atrial muscle driving is
achieved by a highly specialized conduction pathway that stem from the tiny SA node
Central SA node cells
Peripheral SA node cells Atrial myocytes
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center (Boyett et al., 2000). Crista terminalis is devoid of large amounts of connective
tissue and it is particularly enriched in connexins, like the high-conductance Cx43, in clear
contrast with the SA node center (van Kempen et al., 1991), which make it suitable for a
high-speed electrical impulse conduction.
2. Spontaneous generation of pacemaker action potentials
Since Keith and Flack’s discovery lot of efforts have been taken to figure out what
is behind the spontaneous electrophysiological activity of the heart's primary pacemaker.
The ionic currents behind the typically pacemaker AP (Figure 1) have been resolved with
the aid of advanced methodological approaches, such as the patch-clamp technique. SA
nodal cells have an unstable resting potential, lower maximum diastolic potentials and the
highest depolarization rates (phase 4) among other cardiac cell types (Figure 1), so they
set the pace for heart beat (Amin et al., 2010). The remarkable electrophysiological
properties of these cells accounts for the singular expression profile of ionic channels. For
example, these cells lack fast sodium currents which results in lower upstroke velocity
(phase 0) and slower impulse conduction (Boyett et al., 2000) (Figure 1). However,
different AP profiles have been recorded from cells within the SA node area (figure 1),
which goes in line with the proposed heterogeneous cellular population for this area
(Boyett et al., 2000). The distinctive ion channel expression pattern underlies this
electrophysiological diversity. The cells around the SA node center have a phase 0 with
higher slope and amplitude as compared to the centrally located cells, which have a fast
sodium current (INa) (Amin et al., 2010) (Figure 1). Such current supports the higher
impulse conduction velocity at the SA node periphery (Boyett et al., 2000).
The periodical and synchronous APs’ generation is the electrical hallmark of the
SA node and it looks like it has its own clock. The mammalian heart has, forsooth, two
coupled-clocks that drive heart spontaneous activity. The cutting edge coupled-clock
system concept holds a “membrane voltage clock” and the “Ca2+ clock” (Figure 2). The
time-keeping elements in the “membrane voltage clock” are a wide variety of ionic current
from channels and transporters that span the sarcolemma, such as: voltage-dependent
Ca2+ currents (L- and T-type Ca2+ currents); voltage-dependent K+ current (transient
outward current (Ito) and delayed rectifier K+ current that includes ultra-rapid (IK,ur), rapid
(IK,r) and slow (IK,s); “funny” or pacemaker current (If); sustained inward current (Ist),
background sodium-sensitive current (Ib,Na); voltage-independent K+ currents (e.g. ACh-
and ADO-activated K+ current, IK,ACh,ADO; ATP-sensitive K+ current (IK,ATP)); Na+/Ca2+
exchanger (INCX) and Na+/K+ATPase (INaK) currents (Boyett et al., 2000; Lakatta et al.,
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2010). This large ensemble of ionic currents shapes the membrane potential of each AP
on a beat-to-beat basis. The “Ca2+ clock” is based on intracellular Ca2+ dynamics across
the internal (e.g. SR, mitochondria) and external compartments. These two clocks
represent a broad array of synchronized events and, as a result, it is not possible to
detach the membrane clock from the Ca2+ clock, since both interact and mutually
influence each other's activity (Lakatta et al., 2010).
The lack of a stable resting membrane potential (phase 4) is the holy grail of
spontaneous activity of SA node cells (Figure 1). During the mid-diastolic depolarization
(phase 4), Ca2+ from the SR is continuously leaking out through ryanodine-sensitive
channels (RyR2), i.e. local Ca2+ releases (LCRs), increasing cytosolic Ca2+ concentration
([Ca2+]i) that, in turns, drives the depolarizing Na+/Ca2+ (NCX) current (three sodium ions
are exchanged for each Ca2+). The rate of LCRs generation gradually increases during the
late diastolic depolarization that precedes the next AP upstroke (Huser et al., 2000). The
Ca2+ cycling beneath the spontaneously generation of LCRs is closely linked to
spontaneous cycle length and it is regulated by mechanisms that affect both sarcoplasmic
and cytosolic Ca2+ concentrations (Figure 2) (Vinogradova et al., 2004; Sanders et al.,
2006). Regarding the Ca2+ cycling regulation concept, in a recent report, the modulation of
mitochondrial Ca2+ buffer capacity, with blockers of Ca2+ pumps and release channels
highlighted the mitochondria as an organelle with an incredible impact on the coupled SR
Ca2+ loading and pacemaker activity of SA node cells (Figure 2) (Yaniv et al., 2012).
Meanwhile, as the membrane potential becomes less negative due to LCR, the
conductance of T-type calcium channels (CaV3) increases in such way that promotes a
further elevation of ([Ca2+]i) (Catterall, 2011) and, consequently, inward conductance of
INCX increases (Huser et al., 2000; Bogdanov et al., 2001; Sanders et al., 2006). Toward
the end of the phase 4 (late diastolic depolarization), high INCX conductance brings the
membrane potential to the CaV1 (L-type) channels threshold activation (about -40 mV). As
Ca2+ enters mainly through activated CaV1 (L-type) channels, and a little bit through
reverse-mode of NCX current at very positive membrane potentials (Em>ENCX) or high
[Na+]i (Sipido et al., 1997), the Ca2+ conductance through RyR suddenly increases and a
sharply elevation of ([Ca2+]i) occurs, i.e. Ca2+-induced Ca2+ release (CICR) (Fabiato, 1983;
Bogdanov et al., 2001; Bers, 2002). Following this massive SR Ca2+ release, the
membrane potential quickly reverses from negative to positive, and a depolarization
occurs. Rather than being a simple electric impulse yielded from the coupled-clock
system, the AP is itself a synchronizing event of the two “clocks”. The occurrence of an
AP empties SR Ca2+ stores and timely inactivates the RyRs, resetting the SR function. If
the AP does not readily take place, the Ca2+ cycling homeostasis is compromised, and the
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spontaneous SR Ca2+ release begins to vanish until it disappears. Therefore, the AP sets
up the timing and magnitude of the diastolic Ca2+ release (Vinogradova et al., 2004).
Figure 2. The coupled-clock pacemaker system. Cells within the SA node generate spontaneous actions potentials. The
spontaneous activity derives from the dynamical interaction of subcellular (Ca2+ clock) and sarcolemmal (M-clock) proteins.
The net Inward current during early diastolic depolarization phase (If and IK decay) raise the membrane potential. As the
membrane potential become less negative, other electrogenic currents increase their own conductance (ICa,T and INCX) and
spontaneous SR Ca2+ leakage (local Ca2+ release) gradually increases, which causes the membrane potential to go even
less negative. Suddenly, an inward Ca2+ current carried by L-type voltage-gated calcium channel triggers a massive SR
Ca2+ release through ryanodine receptors (RyR) that generates the action potential upstroke (phase 0) and membrane
potential reaches a maximum. Meanwhile, outward K+ current increase (hyperpolarizing) and after few milliseconds the
maximum diastolic depolarization potential is reached again. The “clock ticking” is under autonomic control, it speeds up
when β1-adrenoceptors are stimulated by catecholamines and slows down when Gαi protein-coupled receptors (e.g. A1R
and M2R) are activated. Adenylyl cyclase (AC) integrates autonomic signals by changing cAMP formation rate and,
subsequently, PKA activity. This modified representation of the coupled-clock pacemaker system from (Lakatta et al., 2010)
include the recent advances in this research field, where mitochondrial calcium buffering capacity modulates cardiac
pacemaker cell automaticity (Yaniv et al., 2012).
After reaching the maximum depolarization potential, [Ca2+]i decreases as the K+
outward currents increase (IK) and the membrane potential fades out to negative
potentials (phase 3). The [Ca2+]i transient decay is partially attributable to the calmodulin
(CaM) that serves as an important feedback mechanism for restoring  [Ca2+]i to basal
levels (Lakatta et al., 2010; Catterall, 2011). The binding of Ca2+ to CaM deactivates the
ICa,L (Pitt et al., 2001). Even though the negative modulation of ICa,L by CaM leads to [Ca2+]i
reduction, SR pumping by SERCA2, which refuels the Ca2+ clock, and Ca2+ extrusion via
INCX, accounts for the large reduction of [Ca2+]i at the end of AP (Vinogradova et al., 2004;
Lakatta et al., 2010). Additionally, higher K+ conductance during the third phase (Figure 1)
β1-AR
A1R
M2R IK,ACh/Ado
Ca2+
mito
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of the AP strengthens these Ca2+ release recovery mechanisms by enchaining the forward
mode of NCX and by reducing the Ca2+ channel voltage-dependent activation. As soon as
the membrane potential gets closer to –40 mV, the slow, mixed Na+-K+, inward current
pacemaker current (If) gradually increases (DiFrancesco and Tortora, 1991), along with a
time-dependent decay of potassium conductance that push the membrane potential out of
the maximum diastolic potential and a new cycle begins (Figure 1) (Lakatta et al., 2010).
3. Regulation of chronotropy
Despite pacemaker cells have been regarded as a clock, the spontaneous AP
firing at the SA node is not a monotonous process and can speed up or slow down its
ticking. The SA node is an integrated structure that reacts against the instantaneous body
needs. Sympathetic drive increases heart rate while the parasympathetic system does the
opposite. Autonomic control of heart rate is mostly achieved through ACh- and NE-
sensitive receptors placed on the surface of SA nodal cells. In the heart, including the SA
node, the main subtype of receptors sensitive to ACh is the M2R whereas β1-AR is the
most expressed NE-sensitive receptor. While β1-AR is a Gαs-coupled receptor (vide infra)
and stimulates adenylyl cyclase (AC), the Gαi/o-coupled M2 muscarinic receptor (M2R)
inhibits AC decreasing cAMP levels (Figure 2) (Vinogradova et al., 2006; Lyashkov et al.,
2009). Therefore, one can afford a key role for intracellular cAMP levels on chronotropy
regulation. The positive effect of cAMP is attributable to its stimulating effect on protein
kinase A (PKA) activity, an important kinase that winds both M and Ca2+ clocks (Figure 2)
(Lakatta et al., 2010). In fact, the role of the cAMP/PKA pathway for cardiac pacemaking
is more important than anyone could have ever imagined until Vinogradova’s experiments,
which demonstrated that SA nodal cells have surprisingly higher PKA activity and cAMP
levels as compared to other cardiac cell type. Pharmacological modulation of cAMP/PKA
pathway showed that higher PKA activity, rather than cAMP itself, is obligatory for the
basal spontaneous and rhythmic occurrence of LCRs in these cells (Vinogradova et al.,
2006). The steady-state of cAMP levels yields from the balance between the production
and metabolization rates of cAMP by AC and phosphodiesterases, respectively. Besides
manipulation of cAMP from its steady-state, the phosphatase activity of some proteins,
like protein phosphotases, also affects phosphorylated proteins by PKA and Ca2+/CaM-
dependent protein kinaseII (CaMKII), which may bring forth changes in pacemaker AP
firing (Figure 2) (Lyashkov et al., 2009; Lakatta et al., 2010).
In the early diastolic depolarization phase, perturbation of cAMP equilibrium may
also affect gating properties of HCN (hyperpolarization-activated cyclic nucleotide-gated)
channels and increase their carried current (If) during stimulation of AC or inhibition of
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phosphodiesterases (DiFrancesco and Tortora, 1991). However, in some experiments,
direct pharmacological suppression of If did not produce extensive changes in the
automaticity of SA nodal cells (Sanders et al., 2006; Lyashkov et al., 2009).
Besides AC inhibition, vagal stimulation also decreases spontaneous firing by
increasing K+ conductance (IK,ACh) through G protein-coupled inwardly-rectifying potassium
channels (GIRK/KIR3) accompanied by a detectable hyperpolarization of the maximum
diastolic potential (Han and Bolter, 2011). Activation of GIRK/KIR3 channels were the first
effectors to be described for Gβγ dimer (Logothetis et al., 1987). GIRK/KIR3 channel
belongs to the inward rectifier channels family and it is a heterotetrameric complex of
KIR3.4 and KIR3.1 subunits (Krapivinsky et al., 1995). This ionic current is shared by other
Gαi/o-coupled receptors such as the A1R that also reduces heart beating (Kurachi et al.,
1986; Belardinelli et al., 1988).
Ca2+ ion is more than a simple power source of pacemaker APs; it also acts as a
gear in the “clocking machine”. It accelerates its own dynamics by a feedforward
mechanism based on Ca2+ stimulation of several enzymes, including some AC isozymes,
PKA and CaMKII, and, in its absence (i.e. in the presence of Ca2+ chelators) spontaneous
AP firing are no longer observable (Sanders et al., 2006). These kinases phosphorylate
sarcolemma (e.g. CaV1 (L-type) channels) and SR (e.g. phospholamban and RyR)
proteins, increasing the cell Ca2+ load and Ca2+ cycling that mirror higher spontaneous AP
firing (Lakatta et al., 2010). The relation between overall Ca2+ dynamics and spontaneous
firing come together to define the LCR period, i.e. the time-course that separates the
spontaneous emergence of two LCR events. The LCR period is inversely related to
pacemaker AP length and decreases when some of the AP phases are shortened. The
diastolic depolarization phase (phase 4) underlies the spontaneous SR Ca2+ release, or
LCR, and it is increased by phosphorylation. The frequency and size of LCRs are
enhanced by ryanodine channel (RyR) phosphorylation. When RyR is phosphorylated, the
RyR channel is more sensitive to [Ca2+]i thereby increasing fractional SR Ca2+ release for
a given ICa trigger (Bers, 2002; Vinogradova et al., 2006). RyR channel is not the only
protein phosphorylated from the SR PKA and other kinases also modify the function of
other protein of the SR Ca2+ refueling machinery, namely SERCA2a. SERCA2a is a Ca2+
ATPase responsible for pumping cytosolic Ca2+ into SR and it is naturally inhibited by -
phospholamban. Phosphorylation of phospholamban relieves SERCA2a inhibition,
increasing SR Ca2+ load (Vinogradova et al., 2006). Noteworthy, in absence of this
compensatory mechanism, higher SR Ca2+ release or low SR Ca2+ uptake would gradually
deplete the SR Ca2+ stores and, concomitantly, slow down, or even stop, the
spontaneously firing in SA nodal cells (Bogdanov et al., 2001; Sanders et al., 2006; Yaniv
et al., 2012).
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Given the Ca2+-dependence of spontaneous AP firing, it might be expected an
interplay of the well-recognized inositol triphosphate (IP3)-mediated Ca2+ store release
(Berridge, 1993). In fact, a recent study conducted in mouse SA nodal cells addressed
this relevant assumption by studying the expression levels and location of all IP3R
subtypes. More than any other IP3R subtype, IP3R subtype II (IP3R2) was found to be
highly expressed in SA nodal cells as well as in cells from atrioventricular node and atrial
tissue. Furthermore, IP3R2s lie beneath the sarcolemma in close proximity with SR
proteins, and after application of either membrane-permeable IP3, the spontaneous Ca2+
release and pacemaker firing rate increased in the SA nodal cells (Ju et al., 2011). This
study agrees with previous ones about IP3R expression in cardiomyocytes (Lipp et al.,
2000) (see below) and supports chronotropy modulation by receptors coupled to IP3
production.
To sum up, higher [Ca2+]i increases spontaneous AP firing rate in SA node cells
directly related to higher SR Ca2+ cycling (higher load and release) and shorter LCR
periods (Yaniv et al., 2012). As a consequence, the late phase of diastolic depolarization
slope increases and ICa,L threshold is easily overcome. Inward CaV1 (L-type) current is
also a phosphorylation target of PKA and other kinases that increase ICa,L amplitude and
bring it to earlier phase of diastolic depolarization due to shifting of channel gating to more
negative potentials (Vinogradova et al., 2006; Catterall, 2011).
4. Excitation-contraction coupling
The spontaneous AP firing at the SA node has the heart muscle contraction as the
final goal. The heart muscle has, in turn, to generate enough mechanical energy to impel
the blood through vessels and tiny capillaries. But when a heart impulse is no longer able
to induce an efficient contraction (e.g. during arrhythmic phenomena), the heart works in
an unsustainable way in a medium to long term. Therefore, every AP generated at the SA
node must produce a contraction, which means a coupling between the electrical
excitation and the heart muscle contraction: the excitation-contraction coupling (E-C
coupling) (Figure 3) (Bers, 2002). The E-C coupling underlies a complex cascade of
events that happen in a well-ordered way in just a few milliseconds. The E-C coupling
arises from the overlapping mechanisms behind contraction and electrical activity of the
heart. The sarcolemma is the place where these two phenomena meet. Here, some of the
mechanisms for pacemaker potential generation are as well involved on the E-C coupling
mechanism to generate a contraction. Fundamentally, heart muscle contractions arise
from the synchronous contraction of a large number of cells, and feeling the pulse just
gives us an idea about how powerful and stronger they can be. The heart muscle is
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nothing more than a well-organized and repetitive tridimensional structure composed by
millions of rod-shaped cells running parallel to heart’s surface. These cells are gifted in
terms of contractile machinery and they are usually called myocytes. The sarcomere is the
functional contractile unit of myocytes, and the assembly of repeating sarcomeres, packed
side-by-side, defines a myofibril. Bundles of myofibrils enclosed by the sarcolemma
membrane draw the myocyte. Myofibrils are a large ensemble of thick (myosin filaments)
and thin filaments (actin, tropomyosin and troponin) longitudinally disposed in a symmetric
and parallel way. Running transversely or even longitudinally to myocytes, intercalated
discs have desmosomes that firmly tight adjacent myocytes making them twitch
simultaneously, i.e. a syncytium. Intercalated discs are filled with connexins (gap
junctions) that provide low-resistance pathways for electrical and chemical transmission
between myocytes.
Contrary to pacemaker cells, the atrial and ventricular myocytes have stable
resting potentials (around -85 mV) (phase 4) generated by an outward K+ flux (IK1) through
Kir2 channels (Figure 1) (Boyett et al., 2000; Chandler et al., 2009; Amin et al., 2010).
Spreading of depolarizing waves generated from the leading pacemaker through gap
junctions excite adjacent myocytes by dramatically increasing their Na+ conductance
through voltage-dependent Na+ channels (phase 0). Inward sodium current produces a
sharp upstroke in the membrane potential and then produces a long-lasting increase of
Ca2+ ion conductance through voltage-dependent CaV1 (L-type) channels (Figure 1). CaV1
(L-type) channels change their own Ca2+ conductance in response to membrane potential
and, therefore, they are called voltage-gated channels (Catterall, 2011). Once membrane
potential reaches the maximum depolarization potential, INa deactivation and increase of
transient outward K+ current (Ito) take place to produce an early repolarization (phase 1).
The ICa,L and the gradually K+ conductance increase of voltage-dependent K+ channels
(delayed outward rectifying currents: IKur, IKr and IKs) contribute to the plateau phase of the
AP (phase 2). The successive activation of outward rectifying currents (IKr, IKs and IK1)
deactivates CaV1 (L-type) channels leading to a net outward ionic current that drives
membrane potential toward K+ equilibrium (phase 3 and 4) (Figure 1) (Amin et al., 2010).
Along with the electrophysiological changes produced by an AP from a neighborhood
myocyte, Ca2+ ions passing through CaV1 (L-type) channels increase subsarcolemmal
Ca2+ concentration from 100 nM to 10 µM (Ca2+ spike). CaV1 (L-type) channels are
remarkably located in the well-known transverse tubules of a sarcomere’s Z-disk. The
acclivitous surface of cardiomyocytes is replenished of these specialized structures,
where the CaV1 (L-type) channels are closely connected with clusters of RyR2 from the
SR, forming the cytosolic cleft (or dyadic junction), which is the functional unity of the
cardiac E-C coupling – the couplon (also known as Ca2+ release units) (Figure 3) (Sun et
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al., 1995; Catterall, 2011). In general, the fundamental processes beneath EC-coupling of
ventricular myoctes are very similar to those present in atrial myocyte contraction (Bers,
2002). However, there are some differences between atrial and ventricular myocytes that
lastly influence the contraction properties of these two cell types. While in ventricular
myocytes t-tubules are deeper invaginations of sarcolemma that occupy a large surface of
these cells (around 50%), atrial myocytes have few and less-developed t-tubules.
Offsetting the lack of t-tubules, atrial myocytes have an extensive tubular network formed
from internal SR membranes, also known as Z-tubules at the Z-line level. The distinctive
rearrangement of this tubular system within atrial myocytes mirrors a differential location
pattern of several key pieces involved in EC-coupling driving such as RyR and CaV1 (L-
type) channels. Two populations of RyR channels are usually found in atrial myocytes,
namely junctional and non-junctional RyR populations. Junctional RyR population are
clusters of RyRs just localized beneath the sarcolemma, whereas non-junctional RyR
channels represent the bulk population of RyR channels placed deeply inside of atrial
myocytes (Bootman et al., 2011). CaV1 (L-type) channels from ventricular myocytes are
mostly located in the t-tubules whereas functional CaV1 (L-type) channels of atrial
myocytes are mainly restricted to their periphery (Mackenzie et al., 2004).
When an AP arrives at the sarcolemma of a certain myocyte, almost
instantaneously (<1 ms), Ca2+ ions passing through CaV1 (L-type) channels “pull the
trigger” and large amounts of SR Ca2+ are then released through RyRs, i.e. the CICR
(“Ca2+-induced Ca2+ release”). The close proximity of RyR to CaV1 (L-type) channels from
sarcolemma means that junctional RyRs are much more sensitive to Ca2+ concentration
changes within the dyadic junction and therefore much important for CICR than RyRs not
junctionally located (Bootman et al., 2011). CICR creates a Ca2+ wave that sweeps over
the entire myoplasm (Fabiato, 1983; Sipido et al., 1997; Bers, 2002; Cheng and Lederer,
2008). The recent laser scanning confocal microscopy techniques, together with the new
generation of Ca2+ sensitive fluorescent probes is currently helping to get a deep insight
into CICR phenomenon and how it is regulated. Rather than an isolated event, this
massive [Ca2+]i transient is a spatio-temporal summation of many Ca2+ sparks produced
by numerous CICR events across the entire t-tubular system (Cheng and Lederer, 2008).
Notwithstanding, under basal conditions, spontaneous Ca2+ sparks occur just by
fluctuations of sarcoplasmic and cytosolic free Ca2+ concentrations and appear to be
identical to ICa,L-evoked ones in terms of amplitude, kinetics, and spatial properties.
However, AP-evoked Ca2+ sparks have higher frequencies (≈ 100 fold) when compared to
spontaneous ones and, consequently, the latter have an overall Ca2+ transient usually too
small to induce an E-C coupling (Cheng and Lederer, 2008). Thus, rather than a simple
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local Ca2+ diffusion, CICR implies a precise engagement of numerous RyR/CaV1 (L-type)
channels complexes.
Elicited Ca2+ sparks from ventricular myocytes are globally homogenous than
those elicited in atrial myocytes, probably due to the above described ultrastructural
differences between these two cell types.  Atrial Ca2+ sparks are generated at the cellular
periphery where junctional RyRs are located; they spread laterally till eventually they
reach the centre of these cells (Mackenzie et al., 2004). As demonstrated by Mackenzie et
al., under basal conditions Ca2+ movement toward internal Ca2+ stores (SR) is hindered by
Ca2+ buffering properties of mitochondria and SERCA pumps. Therefore, atrial myocytes
have a contractile reserve formed by internal SR Ca2+ store gated by non-juctional RyRs
that are promptly recruited to enhance myocytes contractility during positive inotropic
stimuli (e.g. adrenergic stimulus) (Mackenzie et al., 2004).
Other channels and transporters may also induce CICR [e.g. CaV3 (T-type)
calcium channels, reverse-mode NCX] even though their role is not as important as the
CaV1 (L-type) channels for E-C coupling (Sipido et al., 1997; Bers, 2002). During CICR,
CaV1 (L-type) channels are mainly deactivated by a Ca2+-dependent mechanism mediated
by CaM (Pitt et al., 2001; Catterall, 2011; Best and Kamp, 2012) while RyR channel
undergoes an inactivation period and only becomes ready to fire when SR Ca2+ backs to
diastolic levels (Bers, 2002).
Although CICR is an all-or-nothing phenomenon, E-C coupling paradoxically
exhibits a graded response that is dependent on amplitude and duration of ICa,L (Bers,
2002). Several theories have emerged to explain this mysterious response but none, so
far, has been completely conclusive (Cheng and Lederer, 2008). Essentially, E-C coupling
is a function of amplitude and duration of global [Ca2+]i transients that accounts for the
number and properties of discrete Ca2+ releasing units timely recruited by an AP (Bers,
2002; Cheng and Lederer, 2008). The number of evoked [Ca2+]i transients is voltage
dependent whereas the single properties of each “couplon” is voltage-independent
(Cheng and Lederer, 2008). For example, RyR channel gating properties, a key point for
“couplons” regulation, is modulated by different ways (vide infra) such as: SR Ca2+ levels;
post-transdutional modifications (e.g. (de)phosphorylation) and other protein-protein
interactions (Bers, 2002).
The amount of Ca2+ released to cytosol during CICR largely exceeds the bulk
intracellular Ca2+ concentration (from ≈ 100 nM to ≈ 1 µM) needed for contraction. In the
resting state, or diastole, thin and thick filaments are partially superimposed, troponin I
(TnI) is connected to actin hiding myosin binding sites on the actin molecule, and myosin
“heads” have bound ATP molecules. This remains stable until the increase of cytosolic
Ca2+ during an AP. As the Ca2+ signal penetrates deeper into the cell, large amounts of
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Ca2+ bind to low affinity troponin C (TnC) sites inducing a structural change in the troponin
complex that switches-on the contractile machinery. By pulling TnI off, Ca2+ binding to
TnC exposes myosin-binding sites throughout actin filament (de Tombe, 2003). As soon
as the myosin heads bind to actin filaments, the force-generating actin–myosin reaction
hydrolyses ATP for the elastic bending and active tilting of myosin heads. The movement
of myosin heads push the actin filaments and induce a decrease in sarcomere length, i.e.
contraction (systole) (de Tombe, 2003). During sarcomere shortening, the Ca2+-affinity of
TnC gradually increases thereby more cross-bridges react with thin filaments, which
explains cooperative activation of cardiac myofilaments (Bers, 2002; Solaro, 2008).
At the end of systole, the cytosolic Ca2+ concentration goes down, and then the
contractile process is resumed getting it ready to fire to a new AP. When [Ca2+]i drops to
diastolic levels, the labile connection between Ca2+ and TnC is broken switching off the
contractile machinery, and relaxation occurs. The relaxation process also needs synthesis
of new ATP molecules to displace the ADP bound to myosin heads. Noteworthy, if
cytosolic Ca2+ is not quickly removed the thin and thick filaments will continue to slide past
each other decreasing even more the sarcomere length. Thus, the cardiac cycle depends
on the kinetics and amount of cytosolic Ca2+ released in early systole and its withdrawal
during diastole. The mechanism underlying this [Ca2+]i drop is highly effective and similar
to what happens in SA nodal cell SERCA and NCX (driven by Na+-K+ pump) removes the
cytosolic Ca2+ into SR and to extracellular milieu, respectively. The plasma membrane
Ca2+ ATPase (PMCA) and mitochondrial Ca2+ uniport also have an important role,
although less important than the other ones, in driving Ca2+ out of the cytosol (Bers,
2002). These cytosolic Ca2+ removal mechanisms, aided by Ca2+ buffering molecules, are
critical not only for relaxation but also to prevent the deleterious cellular effects produced
by high cytosolic Ca2+ concentrations. However, the relative impact of each Ca2+ extrusion
mechanism to decrease [Ca2+]i may change between species as well as in pathological
conditions (Bers,2002). In non-pathological conditions, the active Ca2+ concentration that
induces a contraction is short-lived due to the highly efficient Ca2+ extrusion mechanisms
present in myocytes. Reasonably, any perturbation on Ca2+ extrusion mechanisms yields
an alteration of intracellular Ca2+ dynamics.
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Figure 3. The excitation-contraction (E-C) coupling. Once an action potential (AP) reaches the t-tubular system of
cardiomyocytes, Ca2+ entry through L-type voltage-gated calcium channels (ICa) ignites Ca2+-induced SR Ca2+ release via
ryanodine receptors (RyR), thus raising cytosolic Ca2+ concentration [Ca2+]i. Then, higher [Ca2+]i switches on the contractile
machinery that allows myocyte contraction. Just before reaching maximum active tension, the [Ca2+]i drops to diastolic
levels and muscle undergoes relaxation. Ion pumps (SERCA2a, PMCA and Na+/K+-ATPase pump), exchanger (Na+/Ca2+
exchanger) and mitochondrial Ca2+ uniport drive Ca2+ removal from cytosol. Catecholamine (NE) binds to β-adrenoceptors
(β-AR) and enhances adenylyl cyclase activity that further enhances the activity of cAMP-dependent protein kinase (PKA),
whereas the opposite is true for Gαi/o-coupled receptor (e.g. M2R and A1R). PKA phosphorylates several key proteins
related to E-C coupling (e.g. phospholamban, L-type Ca2+ channels (CaV1 (L-type) channels), RyR, inhibitory troponin (TnI)).
During repolarization phase, outward potassium currents (IK) bring sarcolemmal potential to diastolic potentials. GIRK/KIR3
channel opening following A1R and M2R activation also accelerates the repolarization phase of APs. At the bottom of the
figure, a typical action potentials, [Ca2+]i transient and active tension generated during myocyte contraction are plotted as
function of time (Adapted from (Bers, 2002)).
5. Regulation of Inotropy
The contraction strength of atrial and ventricular myocardium, also called as
inotropy, has a large impact on stroke volume. Regulation of inotropy can be broadly
achieved by interfering with either intracellular Ca2+ handling, myofilament Ca2+ sensitivity
or cross-bridge kinetics (Bers, 2002; Solaro, 2008). Once again protein kinases and their
downstream targets (often other kinases) have a central role on receptor-transmitted
signal integration for inotropy regulation (Figure 3). Their activities control dynamics and
intensity of cytoplasmic Ca2+-transients triggered by APs that lastly control the
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chemomechanical coupling between Ca2+ and myofilaments. Ca2+-handling comprise
uptake and extrusion mechanism of cytosolic Ca2+ ions, which are quite similar with those
implicated in chronotropy regulation (Figure 2). As mentioned above, E-C coupling shows
a graded response dependent of Ca2+ transients characteristics during a CICR (Bers,
2002; Cheng and Lederer, 2008), which in turns directly modulates the cross-bridge
cycling rate, the number and the force of productive actin-myosin interactions (de Tombe,
2003). The amount of Ca2+ released from each CICR event is strictly related to SR Ca2+
concentration and it is tunable by [Ca2+]i. Essentially, when [Ca2+]i increases, the SR Ca2+
content increases too (increase SR Ca2+ load) and, as a result, the likelihood of RyR
opening is higher. When SR Ca2+ load and RyR activity are both elevated, the magnitude
and frequency of spontaneous local Ca2+ release (Ca2+ sparks) is greater, even though
Ca2+ sparks length remains unchanged (Lukyanenko et al., 1996). Thus, CICR
phenomenon is enhanced by increasing Ca2+ influx, decreasing Ca2+ efflux, or enhancing
Ca2+ uptake into SR (e.g. catecholamines or an increase in stimulation frequency, AP
duration, ICa or [Na+]i) (Bers, 2002). Some of these effects are shared by adrenoceptors
(e.g. β1-AR) and other Gαs-coupled receptors. For example, PKA (and CaMKII) relieves
the tonic SERCA2a inhibition by phospholamban phosphorylation, which increases SR
Ca2+ load and muscle relaxation, phoshorylates RyR channels increasing their Ca2+-
sensitivity and SR Ca2+-leakage, and phosphorylates CaV1 (L-type) channels augmenting
their own Ca2+-conductance (Figure 3) (Kamp and Hell, 2000; Bers, 2002; Vinogradova et
al., 2006; Catterall, 2011).
In addition, Gαq-coupled receptors have been allocated to CICR mechanism. Gαq-
protein stimulates inositol phospholipids hydrolysis that, in turn, enhances IP3R-induced
Ca2+ store release (Berridge, 1993) and activates protein kinase C (PKC) (Nishizuka,
1992). PKC family is a group of serine/threonine kinases isoforms generally divided into 3
groups based on their structure and co-factors required for activation, namely:
conventional PKCs (cPKCs: α, βI, βII and γ) require Ca2+, phospholipids, DAG (or phorbol
ester) for activation; novel PKCs (nPKCs: δ, ε, θ and η) are quite related to the
conventional family but they are Ca2+-independent; atypical PKCs (aPKCs: ζ and λ) are
totally different from other family because they are not activated by DAG or phorbol esters
neither by Ca2+ ions (Puceat and Vassort, 1996). PKC δ and ε were the major isozymes
found in cardiomyocytes, at least in rats (Yang et al., 2009b). PKC activation implies a
translocation by receptor for activated protein kinase C (RACKs) and anchoring to specific
cellular structures (Fenton et al., 2009). Regarding the IP3 role on inotropy, IP3R2 is by far
the highest IP3 receptor subtype expressed in cardiomyocytes, with a 6-fold relative
abundance in atrial myocytes when compared to ventricular ones. Moreover, IP3R
activation increases the rate and magnitude of spontaneous Ca2+ sparks (Lipp et al.,
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2000). Interestingly, Lippin and colleagues found that this IP3 receptor subtype is
strategically placed near the Ca2+-release units at the subsarcolemmal region and,
curiously, located in the vicinity of IP3 generation sites where enzymes (e.g. PLCβ) and
Gαq protein-coupled receptors are placed. Interestingly, IP3 seems to recruit a contractile
reserve embraced from non-junctional regions of atrial myocytes (Mackenzie et al., 2004).
Rather than truly effectors of CICR, it is thought that IP3Rs act as positive modulators of
E-C coupling (Lipp et al., 2000; Bers, 2002).
Besides length and amplitude of intracellular Ca2+ transients, the contraction force
development depends on the myofilament Ca2+ sensitivity. Myofilament Ca2+ sensitivity
can be changed by several factors such as: post- translational modifications (e.g.
phosphorylation), stretch, pH, Pi and Mg2+ levels (Bers, 2002).
PKA and PKC are by far the most studied kinases related to phosphorylative
regulation of myofilament mechanics. Other kinases, such as protein kinase G and
CaMKII as well as myosin-light chain kinase also have an active role in myofilament
regulation (Solaro, 2008). In general, myofilament phosphorylation decreases the
sarcomere sensitivity for Ca2+, which means that higher [Ca2+]i is needed for a given
contractile response as compared with lower levels of phosphorylated contractile
proteins(de Tombe, 2003). Numerous GPCRs are targeted for myofilament modulation by
phosphorylation, such as the well-know β1-AR. Sympathetic activation increases force of
contraction, chronotropy and lusitropy. In this situation, as the maximum rates of both
tension development and relaxation increase, the time-course of each contraction
decreases. Myofilament proteins are also phosphorylation targets by other kinases (e.g.
PKC) showing sometimes similar and overlapping responses (Puceat and Vassort, 1996;
Solaro, 2008). In general, TnI phosphorylation by PKA or PKC, induces conformational
changes in troponin complex decreasing TnC-affinity for Ca2+ along with an increase in
kinetics of actin-cross bridge reaction (Solaro, 2008). Thus, phosphorylation of thin
filament proteins increases the turnover of myosin-actin cross-bridges, explaining the
positive inotropy and lusitropy during adrenergic stimulation. Noteworthy, phosphorylative
regulation is not so obvious and site-specific phosphorylation of myofilament proteins
through isoform-specific kinases must not be overlooked. In fact, TnI (and other
sarcomeric proteins) have multiple phosphorylation sites that exhibit isoform-specific
phosphorylations by different kinases, sometimes classified as PKC sites or PKA sites,
which may contribute somewhat to the existence of opposing and ambiguous effects
described in literature (Solaro, 2008). For example, Wang et al. reported an increase in
myofilament Ca2+ sensitivity by the PKC-βII phosphorylation of a specific site (Thr 144) on
cardiac TnI in ventricular myocytes from mice (Wang et al., 2006). In the same line, but
without identifying the isoform, PKC activity was connected to myofilament Ca2+
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sensitization and phosphorylation of TnI and cardiac myosin binding protein-C promoted
by a positive inotropic effector (Cazorla et al., 2009). On the other hand, other PKC
isozymes have been allocated to a negative cardiac inotropy, namely PKCα. (Liu et al.,
2009). This PKC has been connected to Ca2+-handling changes and negative inotropy,
and its inhibition have demonstrated better outcomes in a mice model of heart failure (Liu
et al., 2009).
Interestingly, specific regulation of myofilaments either by kinases or
phosphatases may be relevant in some cardiovascular diseases if we take into account
that some pathological conditions hold distinct protein expression/activity backgrounds.
However, the functional effect of this site specific regulation on myofilament proteins is still
ill-defined and additional work has to be done (Puceat and Vassort, 1996; Solaro, 2008).
Other important mechanism for myofilament Ca2+ sensitivity arise from the
physiological relation between diastolic filling (preload) and cardiac output (heart rate x
stroke volume), i.e. the Frank-Starling mechanism (Allen and Kentish, 1985; de Tombe et
al., 2010). Thus, heart has itself an intrinsic mechanism that dynamically adjusts the active
tension generated for a given diastolic blood volume. As the end-diastolic volume
increases, the passive tension also increases (preload tension) and more tension is
developed in ventricular myocytes. There is a clear relation between sarcomere length
and muscle contractility that has, as its basis, the increase of myofilament Ca2+ sensitivity
together with an increase of the number of successful cross-bridges number and also
contractile force (Allen and Kentish, 1985). Despite the mechanism beneath this
“myofilament length dependent activation” has been extensively studied, a clear theory
that fits all experimental data is still lacking (de Tombe et al., 2010).
6. Adenosinergic triad: metabolism, receptors and function
6.1. Adenosine metabolism
ADO is an endogenous purine nucleoside implicated in many cellular key functions
like nucleotide biosynthesis, amino acid metabolism and several energetically costly
processes (Shryock and Belardinelli, 1997). Therefore, ADO is ubiquitously present in all
cell types and, upon stressful stimuli (e.g. hypoxia, ischemia and adrenergic stimulation)
its extracellular concentration quickly rises up (Sparks and Bardenheuer, 1986). In such
situations, where oxygen supply is decreased and/or oxygen consumption is high, ADO
released from metabolically compromised cells acts as a retaliatory metabolite decreasing
energetic demand / supply ratio (Berne, 1963; Sparks and Bardenheuer, 1986). Metabolic
impairment is not the only way to promote ADO release from cells other physiological and
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pathological stimulus (e.g. inflammation, stretching) could also enhance ADO release
levels (Headrick et al., 2011). Regardless, adenosinergic system is not restricted to
retaliation, it also exhibits regulatory and more sustained adaptive responses, which are of
great importance for the acute fine-tuning of many cellular processes under physiological
conditions, but also for orchestrating structural and functional changes in the diseased
cardiovascular system (Headrick et al., 2011).
In cardiac territory, cardiomyocytes, endothelial cells, and smooth muscle are the
main sources of purines, but under oxygen deprivation purines derived from myocardial
cells assumes particular importance (Shryock and Belardinelli, 1997). ADO metabolism is
compartmentalized and it can be generated from both extracellular and intracellular
compartments, the latter being responsible over 90% of the total ADO production in
normoxia (Deussen, 2000). The extracellular ADO generation pathway comprises the
enzymatic catabolism of adenine nucleotides (ATP, ADP and AMP) by nucleotide-
converting ectoenzymes located on the surface membrane of many cells (Figure 4)
(Yegutkin, 2008). Adenine nucleotides significantly rise in the extracellular milieu during
low oxygen tension and high cardiac sympathetic drive (Vassort, 2001). Leakage of
adenine nucleotides to the extracellular medium exposes them to the action
ectonucleotidases action, which quickly metabolizes ATP and ADP into AMP. AMP is then
irreversibly desphosphorylated to ADO by 5’-ectonucleotidase (CD73) (Deussen, 2000).
Interestingly, before complete dephosphorylation takes place, extracellular nucleotides
can exert a wide variety of signaling effects in cardiovascular regulation by acting on P2
receptors family that are further divided into ionotropic P2X1-7 and metabotropic
P2Y1,2,4,6,11,12,13,14 receptors (Figure 4) (Erlinge and Burnstock, 2008).
The main source of ADO is the intracellular pool of 5´-AMP, which undergoes
dephosphorilation by cytosolic 5’-ectonucleotidase (Deussen, 2000; Headrick et al., 2011).
Hydrolysis of s-adenosylhomocysteine is another intracellular source of ADO (Schrader et
al., 1981). Stressful insults increase both extracellular and intracellular ADO generation
pathways (Shryock and Belardinelli, 1997). In truth, energy status impairment dramatically
increases about 61- to 73-fold ADO production rate as compared to basal conditions in
the rat heart (Deussen, 2000). In such conditions, the amount of intracellular ADO is so
high that ADO kinase, mainly responsible for its rephosphorylation, and ADO deaminase,
which deaminates ADO to inosine, are saturated and are no longer able to stop the
massive release of ADO and other nucleotides (Deussen, 2000). ADO and other
nucleotides come to extracellular medium by facilitated transport through nucleotide
transporters that span the cellular membrane. ADO and its nucleotides can also appear in
the interstitial fluid by other mechanisms such as: cell damage; exocytosis; hemichannels
and other ionic channels (Fredholm et al., 2011). Once in the extracellular medium, ADO
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binds and stimulates its sensitive receptors (see below, Figure 4). After exerting its
signaling effects, ADO is promptly removed from ADO receptors vicinity, thus localizing
their effects to ADO releasing sites. This is accomplished by different mechanisms, in
rough order of importance: cellular uptake through nucleoside transporters driven by ADO
kinase and through enzymatic deamination by either intra- or extracellular ADO
deaminase. If ADO removal does not take place (e.g. with dipyridamole), its extracellular
concentration rises and, consequently, adenosinergic signaling increases (Shryock and
Belardinelli, 1997; Deussen, 2000).
Figure 4. Metabolism and signaling properties of adenosine (ADO) and its nucleotides. Nucleotide-hydrolysing pathway
comprises at least three ectoenzymes namely: ecto-nucleotide pyrophosphatase/phosphodiesterase (E-NPP), (E-NTPDase)
and ecto-5’-nucleotidase (CD73). CD73 can be found in both extracellular and intracellular compartments. As extracellular
nucleotides are sequentially inter-converted to ADO they act as ligands for P2 receptors. While ATP activate either
ionotropic P2X or metabotropic P2Y receptors, ADP mainly activate P2Y receptors. Once ADP or ATP are
dephosphorylated to AMP, it is hydrolyzed to adenosine by CD73. In turns, ADO activates four ADO-sensitive receptors with
different binding affinities for this nucleoside. A1R and A3R are classical described as inhibitors of adenylyl cyclase (AC)
whilst the remaining receptors (A2AR and A2BR) stimulate its activity. Signaling pathways downstream of ADO receptors are
not restricted to modulation of AC or other enzymes, they can also directly change the gating properties of some ionic
channels. AC converts ATP to cAMP as long as the Gαs subunit is activated. Stimulatory effects of cAMP cease by
phosphodiesterase (PDE)-mediated hydrolysis of its phosphodiester bonds leading to AMP formation. Inside cell, ADO is
generated through of either S-adenosylhomocysteine (SAH) or AMP. Termination of adenosinergic signaling involves
deamination ADO to inosine (INO) by ADO deaminase (ADA). Flux direction of adenine nucleosides and nucleotides are
dependent of several factor, including cellular oxygen tension. Modified from (Yegutkin, 2008) and (Deussen, 2000).
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6.2. Adenosine receptors and heart function
Intravenous administration of this nucleoside rapidly slows the sinus rhythm
(negative chronotropism), decreases atrioventricular conduction (negative dromotropism),
and contractile force (negative inotropism), dilates the coronary vessels and also has anti-
arrhythmic effects (Drury and Szent-Gyorgyi, 1929). In the extracellular medium, ADO
exerts protective effects through its binding to ADO-sensitive receptors, also known as P1
receptors. Up to date there are four different ADO receptor subtypes characterized,
namely: A1R, A2AR, A2BR, and A3R (Figure 4) (Fredholm et al., 2011). ADO receptors are
seven transmembrane-spanning proteins that belong to the large family of GPCR. Based
on their preferential coupling to a trimeric G-protein subtype, ADO receptors are classical
divided into stimulators (A2AR and A2BR) and inhibitors (A1R and A3R) of adenylate cyclase
activity (Figure 4). ADO receptors can be further divided into high affinity receptor, where
A1R and A2AR are included, whereas A2BR and A3R receptors have low affinity for their
endogenous ligand at least in rodents (Shryock and Belardinelli, 1997; Fredholm et al.,
2011).
In the whole body, ADO produces a great diversity of effects, in agreement with
the widely expression of ADO-sensitive receptors (Shryock and Belardinelli, 1997;
Fredholm et al., 2011; Headrick et al., 2011). Coronary dilatation is definitively attributed
to stimulatory ADO receptors (Berne, 1963), even though some controversy exists around
the A2 receptor(s) (A2AR and/or A2BR) that mediate(s) coronary vessels dilatation (Shryock
and Belardinelli, 1997; Headrick et al., 2011). The remaining effects above described by
Drury and Szent-Gyorgyi were mostly mediated through A1R activation. Thus endogenous
ADO under stressful conditions, increases heart muscle feeding by increasing coronary
flow while it reduces the overall energy demand by decreasing heart work (Berne, 1963;
Shryock and Belardinelli, 1997; Headrick et al., 2011).
ADO’s net signaling relies on its extracellular concentration, and also on the
relative distribution, compartmentalization and expression pattern of ARs on the surface of
individual cell types that constitutes a specific tissue in which they exist. Impairment of
these signaling checkpoints may underlie the dysfunction observed in some pathological
conditions (Headrick et al., 2011). The connection between ADO receptor and its signaling
effectors is far from easy as so many proteins have been described as important
regulators of adenosinergic signaling. These proteins include different G-proteins types,
arrestins and other scaffold proteins (Verzijl and Ijzerman, 2011), which are organized and
well-compartmentalized in membrane domains (Lasley, 2011). These signaling hotspots
(membrane domains) have attracted much attention of the scientific community, not only
in respect to ADO receptor signaling but to all GPCRs (Patel et al., 2008). Astonishingly, a
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wide variety of experimental data has put forward the hypothesis that several pieces that
gear the adenosinergic system (e.g. ADO receptors, nucleotidases, nucleoside
transporters, signaling effectors) are confined within caveolae domains (Yang et al.,
2009b; Lasley, 2011).
A1R couples to Gαi/o proteins and when activated mediates K+ efflux through the
release of Gβγ (Kurachi et al., 1986) (see below) and decreases PKA activity via inhibition
of AC (LaMonica et al., 1985), counteracting the responses yield from catecholamine
binding to β1-AR, also known as the anti-β-adrenergic effect (Dobson, 1983). Acting on
presynaptic A1R heteroreceptors from sympathetic cardiac nerve endings, ADO derived
from sympathetic transmission refrain exocytotic catecholamine release, further
contributing to anti-β-adrenergic effect (Lorbar et al., 2004). The anti-β-adrenergic effect
seems to be more complex than a simple inhibitory action on AC activity. Recent reports
have demonstrated a PKC-ε activation dependence on the anti-β-adrenergic effect upon
A1R stimulation (Fenton et al., 2009; Fenton et al., 2010). Therefore, A1R may functionally
couple to signaling pathways other than Gαi/o protein-mediated AC inhibition. Recent
evidences clearly suggest that A1R activation rapidly and selectively induces the
translocation of epsilon and sigma PKC isoforms from cytosol to the caveolin-rich
sarcolemma microdomains (Yang et al., 2009b). Previous findings demonstrated a
functional coupling of A1R to PKC-dependent process involving Gβγ subunits and PLC
activation, accompanied by an increase of phospholipid turnover and, sometimes, Ca2+
mobilization (Gerwins and Fredholm, 1992; Dickenson and Hill, 1998; Cordeaux et al.,
2000). However, this secondary pathway should only play a relevant role in tissues with
higher A1R density (Boyer et al., 1992; Biber et al., 1997). Thus, one should take care
when interpreting these data since these atypical effects proposed for A1R depends on the
level of receptor expression and also on the type of agonist present (Ashkenazi et al.,
1987; Biber et al., 1997; Cordeaux et al., 2000; Verzijl and Ijzerman, 2011).
A2AR signaling, as referred above, is primarily mediated via its coupling to Gαs-
protein (Shryock and Belardinelli, 1997), which is sensitive to cholera toxin treatment
(Milligan and Kostenis, 2006). In the working myocardium there are some evidences that
stimulation of this receptor elicit positive inotropic responses (Dobson and Fenton, 1997;
Monahan et al., 2000; Tikh et al., 2006), although this has been challenged by others
(Willems and Headrick, 2007; Chandrasekera et al., 2010). Given the stimulatory nature of
this receptor on AC, which opposes A1R action, A2AR may also control the anti-β-
adrenergic action of A1R (Tikh et al., 2006). The long cytoplasmic tail is also a
characteristic of A2AR, which makes it suitable for interaction with many other proteins that
are summarized elsewhere (Verzijl and Ijzerman, 2011). The recent crystallographic data
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of A2AR will certainly enlarge the number of proteins along with the number of ligands that
interact with this receptor (Lebon et al., 2011).
A2BR is coupled to Gαs-protein and stimulation of PLCβ activity has also been
proposed for A2BR, but its mechanism is still ill-defined, despite some evidence that points
to be mediated via Gαq/11 proteins (Linden et al., 1999). Furthermore, A2BR have direct
positive inotropic properties in the working myocardium since its stimulation increases
cardiac contractility (Chandrasekera et al., 2010).
Finally, the A3R, apart from its conventional coupling to Gαi/o-protein, couples to
Gαq/11 protein (Shryock and Belardinelli, 1997).
6.3. Adenosine and cardiac electrophysiology
For a long time, the scientific community has wondered about what it is behind
ADO effects on cardiac territory. After numerous experiments, it is now recognized that
cardiodepressor effects of ADO are mainly mediated through A1R activation (Belardinelli
et al., 1995). A1R has both direct and indirect effects on supraventricular tissues and only
indirect effects on ventricles of most mammals (Dobson, 1983; Belardinelli et al., 1995).
Cardiac response to ADO exhibits a regional heterogeneity and species dependence,
which possibly takes into account the differential expression pattern of this receptor or its
effectors (e.g. GIRK/KIR3 channels) throughout the heart of different species (Belardinelli
et al., 1995). In fact, when compared with atrium, GIRK/KIR3 channels are weakly
expressed in the ventricular tissue from mammalian hearts (Krapivinsky et al., 1995;
Dobrzynski et al., 2001). In general, the magnitude of cardiac electrophysiological
response to ADO gradually vanishes from the SA node toward ventricles. In ventricles
from several species (e.g. guinea pig, rabbit, bovine, human) it is thought that ADO
exhibits only indirect effects, with exceptions for ferret and rat hearts (Belardinelli et al.,
1995).
Activation of A1R leads to K+ efflux (IKAdo) across the cell membrane (direct effects)
thus reducing cellular electrical excitability (Belardinelli et al., 1988). This hyperpolarizing
current resembles the one elicited by vagally released ACh. In fact, either ADO or ACh
activate the same population of cardiac potassium channels (Kurachi et al., 1986),
currently known as GIRK/KIR3 channels (Krapivinsky et al., 1995). However, A1R-
mediated effects are not restricted to GIRK/KIR3 channels opening, since in GIRK4/KIR3.4-
deficient mice (without IKACh,Ado) a selective A1R agonist was still able to elicit bradycardia
(Wickman et al., 1998), in agreement with recent reports (Lyashkov et al., 2009). This
insensitive bradycardic response to IKACh,Ado suppression (around 50% of the A1R
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response (Wickman et al., 1998)) is probably due to the inhibitory action of ADO on
catecholamine-elicited effects, i.e. the anti-β-adrenergic effect (indirect effects) (Dobson,
1983). The anti-β-adrenergic effect of ADO is explained by the inhibitory nature of A1R on
AC (LaMonica et al., 1985). This enzyme is pivotal for the integration of signals that arise
from Gαs protein-coupled receptors (e.g. β1-AR) (Bers, 2002; Vinogradova et al., 2006;
Lakatta et al., 2010). Interestingly, a recent study demonstrates that SA nodal cells have
high basal levels of cAMP and PKA activity in resting conditions (Vinogradova et al.,
2006). Therefore, in SA nodal cells, A1R stimulation antagonizes catecholamine-
stimulated ionic current (e.g. ICa,L and If) even under basal conditions, and mediates K+
efflux through GIRK/KIR3 channels (Belardinelli et al., 1988).
The dual action of A1R is still present in atrial myocardium (Belardinelli et al.,
1995). ADO mediates negative inotropic responses in supraventricular tissues through its
anti-β-adrenergic effect and activation of IKACh,Ado (LaMonica et al., 1985; Kurachi et al.,
1986). When Gαs protein-coupled receptors of atrial cells are not being stimulated, the
average cAMP content is very low (Vinogradova et al., 2006), hence inhibition of AC on
atrial contraction is not meaningful (Belardinelli et al., 1995). In such conditions, ADO
effects are almost mediated through engagement of direct mechanisms rather than its
anti-β-adrenergic effect (Belardinelli et al., 1988). In addition, some authors have
demonstrated direct and negative effects of ADO (via A1R) and ACh (via M2R) on non-
stimulated ICa,L in atrial cells (about 30% ICa,L reduction) (Cerbai et al., 1988; Visentin et al.,
1990). Conversely, other authors failed to observe any direct effect on these ionic currents
after application of either ADO or ACh under basal conditions (Iijima et al., 1985; Wang
and Belardinelli, 1994). Thus, the inhibition of basal ICa,L is small and seems to require
higher concentrations of agonist than those required to activate IKADO,ACh (Visentin et al.,
1990; Wang and Belardinelli, 1994; Belardinelli et al., 1995). Since ADO accelerates
membrane repolarisation (via IKAdo), the reported reductions of the recorded ICa,L after
ADO/ACh exposure may result from a reduced time available for Ca2+ influx due to
shorter APs (Iijima et al., 1985; Wang and Belardinelli, 1994; Ford and Broadley, 1999).
Furthermore, hyperpolarizing K+ current through GIRK/KIR3 channels opening may also
refrain electrogenic currents present in the rising phase of the AP, namely ICa,L (Amin et
al., 2010), and limit Ca2+ influx into cardiomyocytes, explaining the negative inotropy for
ADO in non-catecholamine stimulated atrium. In an attempt to characterize the biphasic
inotropic effect of ATP observed in diseased human atrium, Gergs and co-workers
unexpectedly observed positive inotropic effects for higher ADO concentrations (above 5
µM) that were sensitive to A1R blockade, even though A1R agonist R-PIA produced only
negative inotropic effects (Gergs et al., 2009). Likewise, selective A1R stimulation elicited
positive inotropy in atria from mice overexpressing A1R, without affecting negative
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chronotropy (Neumann et al., 1999). Therefore, impairment of A1R function may underlie
some of the paradoxical effects observed in the previous studies and emphasize its
relevance in the development of cardiovascular diseases (Headrick et al., 2011). These
inconsistencies certainly deserve further investigations.
The negative dromotropy of ADO is mostly derived by its action in the
atrioventricular node, where it activates hyperpolarizing IKAdo, thereby shortening the
duration, rate and amplitude of APs (Belardinelli et al., 1995). The ADO effect in the
atrioventricular node is particularly important to limit reentrant circuits responsible for
arrhythmogenic episodes (DiMarco et al., 1983). Therefore, ADO and its derivates have
cardiac properties that make it suitable for treatment of some type of supraventricular
tachyarrhythmias (Blomstrom-Lundqvist et al., 2003; Ellenbogen et al., 2005).
Intravenous administration of ADO bolus (Adenocard®), together with the CaV1 (L-
type) channels blocker verapamil, has been extensively used for many years in the clinical
setting for acute conversion of paroxysmal supraventricular tachycardia (PSVT) into sinus
rhythm (DiMarco et al., 1983; Riccardi et al., 2008). ADO, due to its short half-life,
electrophysiological and atrial-selective properties, has also been used as a diagnostic of
certain wide QRS complex tachyarrhythmias (O'Rourke et al., 1999) and assessment of
accessory atrioventricular pathway ablation (Keim et al., 1992). Due to its anti-β-
adrenergic effect, ADO can abrogate ventricular arrhythmias elicited by catecholamines
(Lerman et al., 1986). However, administration of large ADO amounts into bloodstream
has some side effects such as flushing, dyspnea, chest discomfort, and hypotension, but
fortunately they are short-lived and generally not severe (Riccardi et al., 2008). In order to
overcome these side effects, new stable and ADO receptor selective agonists have been
developed and tested in clinical trials. For example, tecadenoson® (CVT-510) is a stable
A1R-selective agonist that already entered clinical trials to circumvent paroxysmal
supraventricular tachycardia and atrial fibrillation, without any significant side effects
reported (Ellenbogen et al., 2005). The powerful electrophysiological effects of ADO may
sensitize supraventricular tissues for rhythmic disorders. Indeed, proarrhythmic episodes
have been reported and connected to shorter atrial AP and refractoriness after ADO
administration (Kabell et al., 1994) and, more recently, to A1R/PLC/PKC pathway, followed
by downstream sarcolemmal Ca2+ entry through transient receptor potential canonical
(TRPC) channel 3 (Sabourin et al., 2012). Therefore, one should consider the likelihood of
arrhythmias development promoted by higher ADO levels in the interstitial fluid of the
myocardium, as observed during hypoxia or ischemia (Berne, 1963; Sparks and
Bardenheuer, 1986)
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II. Aims of research
Heart function matches body needs through numerous neurohormonal agents
released from the myocardium itself, neurons, as well as other molecules secreted into
bloodstream from distant cells. While catecholamines bind to β1-AR to increase cardiac
output, ACh released from vagal fibers activates M2R to break cardiac activity.
Nonetheless, cardiovascular homeostasis cannot be achieved solely through these two
neurohormonal systems; other molecules provide the fine-tuning needed for a
synchronous heart activity with instantaneous body demands. ADO is one of the best-
known molecules involved in regulation and retaliation of the cardiovascular system
(Headrick et al., 2011). Despite decades of research there is still much which remains
unknown about the role of ADO on several physiological and pathophysiological
processes. The physiological and clinical relevance of ADO led us to investigate signaling
events initiated by purinergic receptors in supraventricular tissues. Previous findings from
our lab conducted in spontaneously beating rat atria demonstrated that ADO, via A1R
activation, is an atrial-selective depressant that exhibits a higher sensitivity for chronotropy
than for inotropy regulation (Oliveira-Monteiro et al., unpublished observations). In this
context, the present study was undertaken to investigate the rationale for the A1R-
mediated chronoselectivity in the spontaneously beating rat atria. Since, A1R is
extensively linked to electrophysiological changes through modulation of sarcolemmal
Ca2+ and K+ oscillations, we aimed at evaluating whether A1R chronoselectivity was
somehow connected to the activity of subtype-selective cardiac ion channels and whether
it was also coupled to intracellular enzymatic pathways. To this end, we took advantage of
several techniques that are routinely used by our group, namely in vitro myographic
recordings and laser scanning confocal microscopy to evaluate the function and
distribution of A1R, ionic channels and other downstream effectors. For comparison
purposes, we also evaluated the activity and distribution of M2 receptors in rat atria.
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III. Materials and methods
1. Animals
The experiments were carried out on isolated spontaneously beating atria of
Wistar rats (Rattus norvegicus; 250-300 g) of either sex (Charles River - CRIFFA,
Barcelona, Spain; Vivarium ICBAS, Porto, Portugal). Rats were kept at a constant
temperature (21º C) and a regular light (06.30-19.30h)-dark (19.30-06.30h) cycle, with
food and water ad libitum. The animals were killed by decapitation followed by
exsanguination (Rodent guillotine, Stoelting 51330). Animal handling and experiments
followed the guidelines defined by the European Communities Council Directive
(86/609/EEC).
2. Isolated perfused spontaneously beating rat atria
Isolated perfused beating atria were prepared using a previously described method
(Ford and Broadley, 1999), with minor modifications. In brief, hearts were rapidly excised
and placed in a physiological solution (Tyrode’s solution) composed of (mM): NaCl 137;
KCl 2.7; CaCl2 1.8; MgCl2 1; NaH2PO4 0.4; NaHCO3 11.9; glucose 11.2 and gassed with
95% O2 + 5% CO2 (at pH 7.4). Hearts were allowed to beat freely for a few seconds at
room temperature, to empty its blood content. The paired rat atria were dissected out,
cleaned of fatty tissues, and suspended in a 14-mL organ bath containing gassed
Tyrode’s solution at 37ºC. Each end of the preparation was tied and connected with
thread to the organ bath wall and to an isometric force transducer (MLT050/D; AD
Instruments, Colorado Springs, CO, USA). Changes in isometric tension were recorded
continuously by use of a PowerLab data acquisition system (Chart 5, version 4.2; AD
Instruments, Colorado Springs, CO, USA). The preparations were allowed to equilibrate
for 30-40 min (in perfusion). During this time, tension was adjusted to a final tension of 9.8
mN. This procedure allows atria (with intact SA node) to progressively recover rhythmic
spontaneous beatings.
3. Experimental design
After reaching a steady-state, the perfusion with Tyrode´s solution was stopped
and the preparations were incubated with increasing concentrations of R-(-)-N6-(2-
phenylisopropyl)adenosine (R-PIA, 0.001-1 µM), a stable ADO A1R agonist, or
oxotremorine (0.01-3 µM), a muscarinic M2 receptor agonist, either in the absence and in
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the presence of 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 100 nM) or AF-DX 116 (10
µM), which respectively block A1 and M2 receptors. The A2A receptor agonist, 2-p-(2-
carboxyethyl)phenethylamino-5′-N-ethylcarboxamidoadenosine (CGS21680, 0.3 nM-1
µM) was also tested in some of the experiments. Agonists were added cumulatively to the
bathing solution every 2 minutes.
To examine the role of K+ and Ca2+ channel currents in the effects of ADO A1 and
muscarinic M2 receptors activation, concentration-response curves to R-PIA (0.001-1 µM)
and oxotremorine (0.01-3 µM) were established in the presence of the following inhibitors:
4-aminopyridine (4-AP, 10 µM), a nonspecific voltage-dependent Kv channel blocker,
glibenclamide (10 µM), a selective blocker of ATP-sensitive KATP/KIR6 channels, tertiapin
Q (300 nM), a blocker of GIRK/KIR3 channels with high affinity for KIR 3.1/3.4 channels,
apamin (30 nM), an inhibitor of small-conductance Ca2+-activated K+ (KCa2/SK) channels,
verapamil (1 µM), a selective blocker of high voltage-activated Cav1 (L-type) channels,
and mibefradil (3 µM), a low voltage-activated Cav3 (T-type) channel blocker. The
influence of the PLCβ-PKC pathway on the effects of A1R and M2R stimulation was also
evaluated in this study by using several modulators of this signal transduction pathway:
U73122 (3 µM), a phospholipase C inhibitor, chelerythrine chloride (3 µM), a potent and
cell-permeable inhibitor of several PKC isoforms, phorbol 12-myristate 13-acetate (PMA,
10 µM), a potent and broadly-activator of PKCs, AngII, an endogenous peptide agonist of
angiontensin receptor, and UTP, as an P2Y receptor agonist (particularly P2Y2,4). All the
inhibitors were pre-incubated with the preparations for at least 15 min before R-PIA or
oxotremorine application. The concentrations of the inhibitors in this study were within the
range of channel selectivity described in the literature. To evaluate intrinsic effects of each
drug on spontaneously beating rat atria under basal conditions, concentration-response
curves were constructed for all drugs by adding them in a cumulative stepwise manner
every 2 minutes.
4. Immunofluorescence staining and confocal microscopy studies
Rat hearts were excised (see above) and placed in oxygenated Tyrode's solution
at 33–34°C. Following heart excision the right atrium containing the SA node region and
surrounding atrial muscle was accurately isolated. Tissue fragments were stretched to all
directions, pinned flat onto cork slices and embedded in Shandon cryomatrix (Thermo
Scientific) before frozen in a liquid nitrogen-isopentane bath. Frozen sections with 8 µm of
thickness were cut perpendicular to the crista terminalis of the right atrium (see Figure
5A). Once defrosted, tissue sections were fixed in phosphate buffered saline (PBS)
containing 50% acetone and 2% paraformaldehyde. Following fixation, the preparations
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were washed three times for 10 min each using 0.1 M PBS and incubated with a blocking
buffer, consisting in fetal bovine serum 10%, bovine serum albumin 1%, Triton X-100
0.3% in PBS, for 2 h. After blocking and permeabilization, samples were incubated with
selected primary antibodies (Table 1) diluted in incubation buffer (fetal bovine serum 5%,
serum albumin 1%, Triton X-100 0.3% in PBS), overnight at 4ºC. For double
immunostaining, antibodies were combined before application to tissue samples.
Following the washout of primary antibodies with PBS (3 cycles of 10 min), tissue samples
were incubated with species-specific secondary antibodies (Table 1) in the dark for two
hours, at room temperature. Finally, VectaShield mounting medium, with 4´-6-diamidino-2-
phenylindole (DAPI) to stain the nuclei, (H-1200; Vector Labs) was used to cover-slip the
glass slides. Observations were performed and analyzed with a laser-scanning confocal
microscope (Olympus Fluo View, FV1000, Tokyo, Japan).
Table 1. Antibodies used in immunohistochemistry studies and their technical specifications.
Antibody Host Code Dilution Supplier
Primary Antibodies
A1R Rabbit AB 1587P 1:100 Chemicon
A2AR Rabbit A2aR21-A 1:75 AlphaDiagnostic
M2R Rabbit AMR-002 1:200 Alomone
NF160 Mouse ab7794 1:1000
Abcam
Cx43 Rabbit ab11370 1:700
GIRK1/Kir3.1 Rabbit ab61191 1:500
Cavα2δ-1 Mouse ab2864 1:50
KCa2.2/SK2 Goat AP10032PU-N 1:200
KCa2.3/SK3 Rabbit ab83737 1:300
Secondary Antibodies
Alexa Fluor 488
anti-rabbit Donkey A-21206 1/1500
Molecular
Probes
Alexa Fluor 568
anti-mouse Donkey A-10037 1/1500
Alexa Fluor 568
anti-goat Donkey A-21082 1/1500
The SA node region is found in close proximity to subepicardial sinus node artery
(arrow in Figure 5B). SA node is characterized by a large number of neurofilament 160
(NF-160) positive neuronal fibres (Dobrzynski et al., 2005; Tellez et al., 2006; Allah et al.,
2011), and small-size cardiomyocytes that are negative against connexin-43 (Cx43)
staining, a gap junction protein ubiquitously expressed in the heart apart from in nodal
tissue (van Kempen et al., 1991) (Figure 5C). Cells within SA node are surrounded by
dense connective tissue; collagen fibres (light blue staining) can be differentiated from
cardiomyocytes (red staining) with the Masson’s trichrome staining (Figure 5B).
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5. Masson’s trichrome staining
Masson’s trichrome staining was carried out in right atrial sections from rat heart.
Briefly, right atrial appendage was dissected, excised and immersed in 4% formalin
buffered solution, followed by routine tissue processing for paraffin embedding. Paraffin
blocks were sectioned (≈ 10 µM sections) perpendicular to the crista terminalis of right
atria wall, in a similar manner to that performed for immunfluorescence staining. Paraffin-
embedded sections were dewaxed and rehydrated with xylene followed by a graded
alcohol series [100%, 95% and 70% (v/v) mixtures of ethanol and water] to distilled water.
Atrial sections were subsequently fixed in Bouin’s solution for 1 hour at 60ºC and rinsed in
tap water. Sections were first stained with Celestine blue (5 min) and Gill Hematoxylin 2
afterwards (4 min). Each staining step was followed by a 15-minute washout period in
distilled water. Secondly, a mixture of 1% (v/v) acid fuchsin solution in 1% (v/v) ponceau
de xylidine solution, both in 1% (v/v) acetic acid, was added to sections for 5 min to stain
atrial muscle red. Sections were then washed in distilled water and placed in
phosphomolybdic acid solution (1% [w/v] phosphomolybdic acid) for 15 minutes and later
stained with 2.5 % (v/v) aniline blue solution (in 2.5 % [v/v] acetic acid) during 5 minutes
till new wash with distilled water. After staining procedure, sections were dehydrated
(stepwise increases of ethanol in water from 70-100% [v/v]), cleared (xylene for 2
minutes) and mounted in coverslip slides using D.P.X. mounting medium (Sigma).
Masson’s trichrome technique stains nuclei dark blue whilst muscle and connective tissue
are stained red and blue, respectively. Stained sections were viewed and photographed
using light microscopy (Olympus Fluo View, FV1000, Tokyo, Japan) and Cell F software
(Olympus, Japan) was used to collect the images.
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Figure 5. Anatomical and molecular identification of the rat SA node (A, B and C). A, Endocardial view of a typical rat atrial
muscle-SA node preparation. Dashed lines indicate the orientation of cuts performed on the right atrial appendage for
Masson’s trichrome staining and immunofluorescence analysis. B, High-magnification (400x) images of Masson's trichrome
staining of SA node (dashed box) and surrounding regions; AM, atrial muscle; CT, crista terminalis; ICR, intercaval region.
Red staining, myocytes; blue staining, connective tissue. Black arrow indicates the SA node artery. C, Montage of confocal
optical sections showing immunelabelling for connexin 43 protein (Cx43, green signal) and neurofilament 160 (NF160, red
signal) throughout the right atrial appendage from the rat. Boxes depict representative areas of the right atrium muscle and
SA node used for immunolocalization of receptors and ionic channels.
6. Solutions and chemicals
4-aminopyridine (4-AP), apamin, 2-p-(2-carboxyethyl)phenethylamino-5′-N-
ethylcarboxamidoadenosine (CGS21680C), 1,3-dipropyl-8-cyclopentyl-xanthine (DPCPX),
R-(-)-N6-(2-phenylisopropyl)adenosine (R-PIA), uridine 5′-triphosphate trisodium salt
hydrate (UTP); Angiotensin II human (AngII) were from Sigma-Aldrich (St. Louis, MO,
USA). AF-DX 116, oxotremorine sesquifumarate, 2-Aminoethoxydiphenylborane (2-APB),
phorbol 12-myristate 13-acetate (PMA), chelerythrine chloride, U73122, mibefradil
dihydrochloride and verapamil hydrochloride were from Tocris Cookson Inc. (Bristol, UK);
glibenclamide and tertiapin Q were from Ascent Scientific (Bristol, UK);
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Dimethylsulphoxide (DMSO), serum albumin and Triton X-100 were from Merck
(Darmstadt, Germany).
AF-DX 116, glibenclamide, PMA and 2-APB were made up in DMSO stock
solution. DPCPX was made up in 99% DMSO / 1% NaOH 1 mmol L-1 (v/v). R-PIA,
U73122, verapamil were made up in ethanol; these solutions were kept protected from the
light to prevent photodecomposition. Other drugs were prepared in distilled water. All
stock solutions were stored as frozen aliquots at -20ºC. Dilutions of these stock solutions
were made daily and appropriate solvent controls were used. No statistically significant
differences between control experiments, made in the absence or in the presence of the
solvents at the maximal concentrations used (0.5% v/v), were observed. The pH of the
superfusion solution did not change by the addition of the drugs in the maximum
concentrations applied to the preparations.
7. Presentation of data and statistical analysis
The isometric contractions were recorded and analyzed before and after the
addition of each drug at the desired concentration. Results were presented as
percentages of variation compared to baseline, obtained before the administration of the
evaluated drug. The data are expressed as mean ± SEM, with n indicating the number of
animals used for a particular group of experiments. Spontaneous mechanical tension
(inotropic effect) and contraction rate (chronotropic effect) were evaluated by analysis of
variance, having been selected the most appropriate ANOVA test for each experimental
protocol. IC50 (concentrations of drug producing 50% of the maximal inhibition) values
were obtained by computer-assisted curve fitting of Hill function with variable slopes by
use of the computer program GraphPad Prism (version 4.0, USA). Statistical analysis of
data was carried out by using Student-Newman-Keuls test for paired data. A value of
P<0.05 was considered to represent a significant difference.
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IV. Results
1. Adenosine acting via A1 receptors is a chronoselective atrial depressant as
compared to the muscarinic M2 receptor agonist, oxotremorine
Figure 6 shows that activation of ADO A1 and muscarinic M2 receptors,
respectively with R-PIA (0.001-1 µM) and oxotremorine (0.01-3 µM), decreased in a
concentration-dependent manner the rate (negative chronotropic effect) and the force
(negative inotropic effect) of spontaneous contractions of the rat atria. However, the
negative chronotropic effect of R-PIA (IC50~0.03 µM, Figure 6B) was evidenced at much
lower (~30 times) concentrations than the negative inotropic action (IC50~1 µM, Figure
6B), whereas oxotremorine-induced depression of both the rate and the tension was
observed in the same concentration range (IC50~0.1-0.3 µM) (Figures 6D). Thus, R-PIA is
a chronoselective depressant as compared to oxotremorine in spontaneously beating rat
atria. In fact, low concentration of R-PIA produced a mild positive inotropic effect (100 nM,
+32±10%, P<0.05 vs basal, n=48, Figure 6B), contrary to oxotremorine. Both agonistic
effects were reversibly reverted during the washout period to basal chronotropic and
inotropic states before drug application.
Figure 6. Adenosine is a chronoselective atrial depressant. In right panels (A and C) are depicted representative original
recordings of isometric contractions of rat atrial muscle in response to increasing concentrations of R-PIA (0.001-1 µM) and
oxotremorine (0.01-3 µM), respectively. R-PIA and oxotremorine were applied once every 2 min at increasing
concentrations. In left panels are depicted concentration-response curves of R-PIA (B) and oxotremorine (D) on the
spontaneously beating rat atria. The ordinates are percentage of variation of spontaneous contraction rate (chronotropic
effect) and mechanical tension (inotropic effect) as compared to baseline values obtained before application of the
corresponding agonist. The data are expressed as mean ± SEM from an n number of individual experiments. *P<0.05
compared with the concentration-response curve for the chronotropic effect of the corresponding agonist.
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Figures 7A and B show that selective blockade of ADO A1 receptors with DPCPX
(100 nM), significantly shifted to the right the concentration-response curves for R-PIA
(0.001-1 µM) in the spontaneously beating rat atria. The blocking effect of DPCPX was
dependent on the concentration (2.5, 10 and 100 nM, n=4-6, data not shown), thus
indicating that the A1R must be the dominant receptor involved in the negative
chronotropic and inotropic actions of R-PIA. Increasing concentrations of DPCPX (2.5-100
nM) per se were devoid of effect (P>0.05 vs basal values, data not shown).
Figure 7. Inhibitory effects of R-PIA and oxotremorine on contractile and chronotropic responses are mediated through A1R
and M2R activation, respectively. Concentration-response curves of R-PIA (A and B) and oxotremorine (C and D) on the
spontaneously beating rat atria in the absence (Control) and in the presence of selective A1 (DPCPX) and M2 (AF-DX 116)
receptor antagonists. Oxotremorine (0.01-3 µM) and R-PIA (0.001-1 µM) were applied once every 2 min at increasing
concentrations; AF-DX 116 (10 µM) and DPCPX (100 nM) were added to the incubation fluid 15 minutes before application
of R-PIA or oxotremorine. The ordinates are percentage of variation of spontaneous contraction rate (chronotropic effect, A
and C) and mechanical tension (inotropic effect, B and D) as compared to baseline values obtained before application of the
corresponding agonist. The data are expressed as mean ± SEM from an n number of individual experiments. *P<0.05
compared with the effect of oxotremorine (C and D) or R-PIA (A and B) in the absence of receptor antagonists AF-DX 116
and DPCPX.
Likewise, data from Figures 7C and D show that depression of the rate and the
tension of spontaneous atrial contractions caused by oxotremorine (0.01-3 µM) were both
completely prevented by pre-incubation with the muscarinic M2 receptor antagonist, AF-
DX 116 (10 µM). AF-DX 116 at 10 µM did not produce any significant alterations on
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evaluated parameters (P>0.05 vs basal values). Therefore, the effects of oxotremorine
and R-PIA in the spontaneously beating rat atria are due to activation of M2R and A1R,
respectively.
The chronoselective effect operated by R-PIA in the spontaneously beating rat
atria could be simply explained by a differential expression of A1R between the SA node
and atrial muscle. Immunofluorescence confocal microscopy studies showed that A1 and
M2 receptors are evenly expressed in SA node and atrial cardiomyocytes (Figure 8), thus
indicating that differences in the regional distribution of receptors do not account for ADO
chronoselectivity in the spontaneously beating rat atria. Of note that M2R labeling pattern
was quite different from that observed for A1R. A1R demonstrated both outer cell
membrane and internal labeling, whereas M2R labeling (Figure 8) was strongly present in
the outer cell membrane. The differential labeling pattern between A1 and M2 receptor
might mirror different cellular locations for these receptors.
Figure 8. A1R and M2R are expressed in rat atria. Representative confocal micrographs of the rat SA node and neighboring
atrial muscle showing immunofluorescence labeling of A1 (upper panels) and M2 (lower panels) receptors; the corresponding
differential interference contrast (DIC) images are also shown for comparison. Similar results were obtained in 6 additional
experiments. Horizontal bar=30 µm. The white arrow indicates the SA node artery.
2. Activation of A2ARs are not involved in adenosine chronoselectivity
Even though most cardiac effects of R-PIA had been extensively antagonized with
DPCPX, we cannot dismiss the involvement of A2AR. Therefore, to exclude a possible
interplay of A2AR on the ADO’s chronoselective effect, we evaluated the functional effects
of A2AR stimulation by using its agonist CGS 21680 (0.003-1 µM) on force and rate of
A 1
R
M 2
R
SA nodeAtrial muscle
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contraction of spontaneously beating rat atria. The selective ADO A2A receptor agonist,
CGS21680, when applied in a similar concentration range (0.003-1 µM) as R-PIA (0.001-1
µM), tended to increase basal inotropy (maximal stimulation, ~5% at 300 nM) (Figure 9)
but the effect did not reach statistical significance (P>0.05 vs basal values, n=59). These
findings suggest that the A2A receptor has limited importance in the response to ADO in
the denervated rat atria.
Figure 9. A2AR activation does not play a significant role on atrial inotropy and chronotropy. In the left side is shown the
concentration-response curves of CGS 21680 (0.003-1 µM) in spontaneously beating rat atria. CGS 21680 was applied
once every 2 min at increasing concentrations. The ordinates are percentage of variation of spontaneous contraction rate
(chronotropic effect) and mechanical tension (inotropic effect) as compared to baseline values obtained before application of
CGS 21680. The data are expressed as mean ± SEM from an n number of individual experiments. In the right panels are
representative confocal micrographs of the rat SA node (upper panels) and neighboring atrial muscle (lower panels)
showing immunofluorescence labeling of A2AR; the corresponding differential interference contrast (DIC) images are also
shown for comparison. Similar results were obtained in 2 additional experiments. Horizontal bar=30 µm. The white arrow
indicates the SA node artery.
To support functional results about the meaningless effects of A2AR activation in
rat atria, we used immunofluorescence confocal microscopy to examine the location and
relative expression of this receptor. Images taken from SA node area and atrial muscle
sections immunolabeled for A2AR showed that this receptor is expressed in
supraventricular tissues of rat, but its overall immunoreactivity was very weak, which
suggest a low expression of A2AR in the rat atria (Figure 9).
3. G protein-coupled inwardly rectifying K+ (GIRK/KIR3.1/3.4) channels operate atrial
depression caused by A1R and M2R activation
It is well known from the literature that ADO and ACh share a common signal
transduction pathway that reduces chronotropy and inotropy through direct opening of
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GIRK/KIR3.1/3.4 channels (Kurachi et al., 1986; Krapivinsky et al., 1995; Han and Bolter,
2011). Consistent with a direct action on GIRK/KIR3 channels, the inhibitory effect of R-PIA
and oxotremorine on spontaneous atrial contractions were totally prevented by tertiapin-Q
(300 nM), a selective GIRK/KIR3 channel blocker peptide, seen as a rightward
displacement of the concentration-response curve and reduction of the maximum
response for R-PIA and oxotremorine (Figure 10). Tertiapin Q did not affect spontaneous
atrial contractions when applied once every 2 min at increasing concentrations from 30
nM to 1 µM (data not shown).
Figure 10. Atrial GIRK/KIR3 channels mediate cholinergic and adenosinergic cardiodepression. Concentration-response
curves of R-PIA (A, B) and oxotremorine (C, D) in the absence (Control) or in the presence of tertiapin-Q (300 nM). R-PIA
(0.001-1 µM) and oxotremorine (0.01-3 µM) were applied once every 2 min at increasing concentrations; Tertiapin Q (300
nM), a potassium GIRK/KIR3 channel blocker, was added to the incubation fluid 15 minutes before application of R-PIA or
oxotremorine. The ordinates are percentage of variation of spontaneous contraction rate (chronotropic effect, A and C) and
mechanical tension (inotropic effect, B and D) as compared to baseline values obtained before application of the
corresponding agonist. Vertical lines indicate ± SEM for the indicated number (n) of individual experiments. *P<0.05
compared with the effect of both agonists in the absence of potassium GIRK/KIR3 channel blocker. In the right side of this
figure is present representative confocal micrographs of the rat SA node (upper panels) and neighboring atrial muscle (lower
panels) showing immunofluorescence labeling of GIRK1/KIR3.1 channel subunit; the corresponding differential interference
contrast (DIC) images are also shown for comparison. Similar results were obtained in 6 additional experiments. Horizontal
bar=30 µm. The white arrow indicates the SA node artery.
In addition, GIRK/KIR3 channels expression was examined because of its
relevance as an effector of the atrial depression elicited by A1R and M2R. According to the
functional studies, immunolabeling of GIRK1/Kir3.1 subunits confirmed GIRK/KIR3 channel
expression throughout the right atria including the SA node. It can be seen from confocal
micrographs that GIRK1/Kir3.1 subunits were highly and equally expressed in both SA
node and right atrial muscle cells (Figure 10). Similarly to that observed for A1R
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immunolocalization (Figure 8), Kir3.1 labeling was present in the outer cell membrane and
it was also present inside myocytes.
4. A1R-mediated chronoselectivity is prevented by blocking CaV1 (L-type) channels
and KCa2/SK currents with verapamil and apamin, respectively
Immunolocalization studies showed that differences in the distribution of A1R
between SA node and atrial cardiomyocytes do not afford a rationale for ADO
chronoselectivity. In view of this, the underlying mechanism(s) responsible for ADO
chronoselectivity is possibly downstream the receptor level.
Giving the pivotal role of Cav1 (L-type) channels on E-C coupling and spontaneous
generation of pacemaker AP (Bers, 2002; Lakatta et al., 2010), we aimed at exploring the
rationale for ADO chronoselectivity testing the effect of the nucleoside in the presence of
Cav1 (L-type) channels blockers in the rat spontaneously beating atria. On its own,
blockade of Cav1 (L-type) channels with the phenylalkylamine, verapamil (0.01-10 µM)
(Catterall, 2011), decreased the rate and the strength of contractions of the rat
spontaneously beating atria in a concentration dependent manner (data not shown).
Verapamil, applied in a concentration (1 µM) that reduced atrial chronotropy roughly by
25%, sensitized atria to the negative inotropic action of R-PIA (0.001-1 µM) without much
affecting the action of the A1 receptor agonist on the rate of atrial contractions. The
negative inotropic effect of R-PIA changed from an IC50 value of about 1 µM in control
conditions to 0.1 µM in the presence of CaV1 (L-type) channels blocker. The negative
chronotropic and inotropic actions of R-PIA were both evident in the same range of
concentrations (IC50~0.03-0.1 µM) in the presence of verapamil, thus leading to a loss of
the atrial chronoselectivity of ADO A1 receptors (Figure 11). Conversely, blockade of CaV1
(L-type) channels with 1 µM verapamil failed to modify oxotremorine (0.01-3 µM)-induced
depression in the rat spontaneously beating atria (Figure 12). These findings contrast with
those obtained with the ADO A1 receptor agonist (Figure 11), suggesting that the negative
chronotropic and inotropic actions of oxotremorine are independent on Ca2+ influx through
CaV1 (L-type) channels, relying most probably on the control of K+ currents via GIRK/KIR3
sensitive to tertiapin Q.
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Figure 11. A1R-mediated negative inotropy was potentiated by the L-type calcium channels blockade. Concentration-
response curves of R-PIA on the spontaneously beating rat atria in the absence (Control) and in the presence of voltage-
sensitive calcium channels inhibitors: verapamil (1 µM, A and C) and mibefradil (3 µM, B and D). R-PIA (0.001-1 µM) was
applied once every 2 min at increasing concentrations; voltage-sensitive calcium channels blockers, verapamil (1 µM) and
mibefradil (3 µM), were added to the incubation fluid 15 minutes before application of R-PIA. The ordinates are percentage
of variation of spontaneous contraction rate (chronotropic effect, A and B) and mechanical tension (inotropic effect, C and
D) as compared to baseline values obtained before application of R-PIA. The data are expressed as mean ± SEM from an n
number of individual experiments. *P<0.05 compared with the effect of R-PIA in the absence of voltage-sensitive calcium
channels inhibitors.
Blockade of low voltage-activated CaV3 (T-type) channels with mibefradil (0.1-10
µM) concentration-dependently reduced atrial chronotropy to a maximum of 30% (n=7),
without affecting the force of spontaneous atrial contractions (data not shown). Mibefradil
(3 µM) failed to modify the effects of both R-PIA (0.001-1 µM) and oxotremorine (0.01-3
µM) in the rat spontaneously beating atria (Figures 11 and 12).
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Figure 12. M2R-mediated negative inotropy is insensitive to voltage-sensitive calcium channels blockade. Concentration-
response curves of oxotremorine on the spontaneously beating rat atria in the absence (Control) and in the presence of
voltage-sensitive calcium channels inhibitors: verapamil (1 µM, A and C) and mibefradil (3 µM, B and D). Oxotremorine
(0.01-1 µM) was applied once every 2 min at increasing concentrations; voltage-sensitive calcium channels blockers,
verapamil (1 µM) and mibefradil (3 µM), were added to the incubation fluid 15 minutes before application of R-PIA. The
ordinates are percentage of variation of spontaneous contraction rate (chronotropic effect, A and B) and mechanical tension
(inotropic effect, C and D) as compared to baseline values obtained before application of oxotremorine. The data are
expressed as mean ± SEM from an n number of individual experiments. *P<0.05 compared with the effect of oxotremorine
in the absence of voltage-sensitive calcium channels inhibitors.
Next, it was evaluated whether K+ channels other than GIRK/KIR3 channels were
involved in A1R- and M2R-mediated atrial depression. Like that observed in the guinea-pig
atria (De Biasi et al., 1989), blockade of voltage-gated Kv and ATP-sensitive KATP/KIR6
channels respectively with 4-aminopyridine (4-AP, 10 µM) and glibenclamide (10 µM) had
no significant (P>0.05) effects on the negative chronotropic and inotropic actions of R-PIA
and oxotremorine (Figure 13). Similar results were obtained when the concentration of 4-
AP was increased from 10 to 100 µM (n=6, data not shown).
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Figure 13. A1R is modulated by small conductance calcium-activated potassium channels operation. Concentration-
response curves of R-PIA on the spontaneously beating rat atria in the absence (Control) and in the presence of potassium
channels blockers: 4-AP (10 µM, A and D), glibenclamide (10 µM, B and E), and apamin (30 nM, C and F). R-PIA (0.001-1
µM) was applied once every 2 min at increasing concentrations; potassium channel blockers 4-AP (10 µM), glibenclamide
(10 µM) and apamin (30 nM), were added to the incubation fluid 15 minutes before application of R-PIA. The ordinates are
percentage of variation of spontaneous contraction rate (chronotropic effect, A, B and C) and mechanical tension (inotropic
effect, D, E and F) as compared to baseline values obtained before application of R-PIA. The data are expressed as mean ±
SEM from an n number of individual experiments. *P<0.05 compared with the effect of R-PIA in the absence of potassium
channel blockers.
Contrariwise, blockade of Ca2+-activated KCa2/SK channels with apamin (30 nM)
shifted to the left (P<0.05) the concentration-response of R-PIA (0.001-1 µM) regarding
the negative inotropic component of the A1R action (Figure 13F), without much affecting
the action of the nucleoside on the rate of atrial contractions (Figure 13C). That is, pre-
treatment with apamin (30 nM) sensitized atria to the negative inotropic effect of R-PIA in
a way that the negative chronotropic and inotropic actions of the A1 receptor agonist
became evident in the same range of concentrations (IC50~0.03-0.1 µM) (see above).
These findings suggest that the bradicardic and the negative inotropic actions of ADO
may be dissociated in terms of the intracellular mechanisms being involved. Apamin (30
nM) failed to affect the depressant effects of oxotremorine (0.01-3 µM) in the rat
spontaneously beating atria under similar experimental conditions (Figure 14).
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Figure 14. M2R-mediated negative inotropy is insensitive to small conductance calcium-activated potassium channels
blockade. Concentration-response curves of oxotremorine on the spontaneously beating rat atria in the absence (Control)
and in the presence of potassium channels blockers: 4-AP (10 µM, A and D), glibenclamide (10 µM, B and E), and apamin
(30 nM, C and F). Oxotremorine (0.01-1 µM) was applied once every 2 min at increasing concentrations; potassium channel
blockers 4-AP (10 µM), glibenclamide (10 µM) and apamin (30 nM), were added to the incubation fluid 15 minutes before
application of oxotremorine. The ordinates are percentage of variation of spontaneous contraction rate (chronotropic effect,
A, B and C) and mechanical tension (inotropic effect, D, E and F) as compared to baseline values obtained before
application of oxotremorine. The data are expressed as mean ± SEM from an n number of individual experiments. *P<0.05
compared with the effect of oxotremorine in the absence of potassium channel blockers.
5. KCa2/SK and CaV1 (L-type) channels are expressed both in SA node and atrial
cardiomyocytes
Considering that blockade of KCa2/SK and CaV1 (L-type) channels, respectively
with apamin and verapamil, predisposes atria to the negative inotropic action of ADO, we
tested whether these channels were expressed in the rat atria by immunofluorescence
confocal microscopy.
CaV1 (L-type) channels, like other high-voltage operated Ca2+ channels, are
heteromeric proteins formed by the pore-forming α-subunit together with β, α2/δ and γ
accessory subunits (Catterall, 2011). In the heart the phenylalkylamine-sensitive ionic
current (ICa,L) is mainly attributable to ionic channels containing α1C (CaV1.2) and α1D
(CaV1.3) subunits (Best and Kamp, 2012). In this study we used a commercial available
antibody against the extracellular α2δ-1 subunit to localize CaV1 (L-type) channels in the
rat atria. Although α2δ subunits are present in all high-voltage-gated Ca2+ channels
including L-, P/Q-, N- and R-types, cardiac expression of high-voltage operated calcium
channels other than the CaV1 (L-type) channels subtype is negligible (Catterall, 2011).
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Figure 15 shows that both SA node and atrial cardiomyocytes evenly exhibit
immunoreactivity against the extracellular α2δ-1 subunit of CaV1 (L-type) channels.
Figure 15. The molecular players of A1R-mediated chronoselectivity, KCa2/SK and CaV1 (L-type) channels, are expressed
throughout the rat atria. Representative confocal micrographs of rat right atria and SA node sections showing
immunofluorescence labeling for KCa2.2 (SK2), KCa2.3 (SK3) and CaVα2δ-1 channel subunits (first and third columns); the
corresponding differential interference contrast (DIC) images are also shown for comparison (second and fourth columns).
Similar results were obtained in 5 additional experiments. Horizontal bar=30 µm. White arrows indicate SA node artery.
The concentration of apamin used in this study (30 nM) effectively blocks KCa2.2/
SK2 and KCa2.3/SK3 channels (Ishii et al., 1997), which are probably the subtypes most
expressed in mammalian atria (Chandler et al., 2009; Yanni et al., 2011). Figure 15 shows
that both SA node and atrial cardiomyocytes exhibit immunoreactivity against KCa2.2 and
KCa2.3. Differences might exist in the distribution of apamin-sensitive KCa2.2 and KCa2.3
channels, being the latter more abundant in the SA node as compared with atrial
cardiomyocytes, while the opposite seems to occur regarding KCa2.2.
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6. Chronoselectivity of A1R is dependent on PLC/PKC coupling
Several pieces of evidence showed that A1R activation may stimulate PIP2
hydrolysis linking this receptor to the PLCβ/PKC second messenger system (Kohl et al.,
1990; Gerwins and Fredholm, 1992; Dickenson and Hill, 1998; Cordeaux et al., 2000;
Lester and Hofmann, 2000; Parsons et al., 2000; Fenton et al., 2010). As outlined in the
introduction, modulation of the PKC activity might change contractile parameters, which
led us to investigate PKC and upstream targets of this kinase on ADO-induced atrial
depression. For comparison purposes, we also tested the involvement of the PLCβ/PKC
pathway on muscarinic M2R responses.
Inhibition of PLC with U73122 (3 μM) sensitized atria to A1R contractile
depression. The magnitude of the leftward shift of the concentration-response curve of R-
PIA (0.001-1 µM) was more obvious regarding the negative inotropic effect (Figure 16B)
as compared to the negative chronotropic action of the nucleoside (Figure 16A). The
negative inotropic effect of R-PIA changed from an IC50 value of ~1 µM in control
conditions to 0.1 µM (n=7) in the presence of the PLC inhibitor, U73122 (3 μM). Under
these circumstances, the negative chronotropic and inotropic actions of R-PIA were both
evident in the same range of concentrations (IC50~0.03-0.1 µM) indicating that inhibition of
PLC leads to a loss of the atrial chronoselectivity of A1R. Contrariwise, blockade PLC with
U73122 (3 μM) failed to modify oxotremorine (0.01-3 µM)-induced depression in the rat
spontaneously beating atria (Figures 16C and D). On its own, U73122 (3 µM) was devoid
of chronotropic (-4±4%, P>0.05, n=13) and inotropic (-3±4%, P>0.05, n=13) effects of the
spontaneously beating rat atria (data not shown).
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Figure 16. Inhibition of PLC with U73122 (3 μM) sensitized atria to A1R contractile depression. Concentration-response
curves of R-PIA (A and B) and oxotremorine (C and D) in the absence (Control) or in the presence of the PLC inhibitor,
U73122 (3 µM). R-PIA (0.001-1 µM) (A and B) and oxotremorine (0.01-3 µM) (C and D) were applied once every 2 min at
increasing concentrations. U73122 was added to the incubation fluid 15 minutes before application of agonists. The
ordinates are percentage of variation of spontaneous contraction rate (chronotropic effect, A and C) and mechanical tension
(inotropic effect, B and D) as compared to baseline values obtained before application of R-PIA or oxotremorine. The data
are expressed as mean ± SEM from an n number of individual experiments. *P<0.05 compared with the effect of agonists in
the absence of phospholipase C inhibitor.
Diffusible IP3 and DAG are generated from PIP2 hydrolysis catalyzed by PLC. IP3
is responsible for cytosolic Ca2+ recruitment from SR (Berridge, 1993), thus enhancing E-
C coupling and spontaneous AP firing in the heart (Lipp et al., 2000; Bers, 2002). Taking
this into account, we aimed at investigating whether A1R coupling to PLC (see above)
would generate enough IP3 to levels required to counteract adenosine negative inotropic
action. To test this hypothesis, we sought it would be helpful to block the IP3R with 2-
aminoethoxydiphenylborane (2-APB) prior to R-PIA (0.001-1 µM) application.
Unfortunately 2-APB, used in a concentration (30 µM) within the range of that needed to
inhibit IP3-induced SR Ca2+ recruitment (Maruyama et al., 1997), abolished atrial
spontaneous activity (n=5) (Figure 17). Under these circumstances, the strong inhibitory
effect of 2-APB (30 µM) on atrial activity persisted for a long period of time, even after
washing the drug from the bath. Before atrial arrest, 2-APB (30 µM) caused significant
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mechanical instability characterized by aberrant contractions (Figure 17), as observed by
other authors (Wolkowicz et al., 2007). Given the strong inhibitory effect of 2-APB (30 µM)
on atrial spontaneous activity, no further studies were performed with this compound.
Figure 17. 2-APB abolishes spontaneous atrial activity and induces severe mechanical instability. Representative original
recordings of isometric contraction force of rat atrial muscle. 2-APB at 30 µM was applied to organ bath after an equilibrium
period. Similar results were obtained for 5 experiments.
As mentioned above, beside IP3 formation, PIP2 hydrolysis also generates DAG
which in turn activates several DAG-sensitive PKC isozymes. The concentration-response
curve of the negative inotropic response to R-PIA (0.001-1 µM) was significantly (P<0.05)
shifted to the left by chelerythrine (3 μM), a potent cell-permeable and broad-spectrum
PKC inhibitor (Figure 18B). Like that observed with the PLC inhibitor, U73122 (3 μM),
negative chronotropic and inotropic actions of R-PIA were both seen in the same
concentration range (IC50~0.03-0.1 µM), thus indicating that inhibition of the PLC/PKC
pathway leads to a loss of A1R-mediated atrial chronoselectivity by sensitizing atria to the
negative inotropic action of the nucleoside (Figure 16B and 18B). PKC blockade with
chelerythrine (3 μM) did not modify oxotremorine (0.01-3 µM)-induced depression in the
rat spontaneously beating atria (Figures 18C and D). Cumulative application of
chelerythrine (0.03-3 µM) per se did not have a major impact (P>0.05 vs basal values) on
atrial chronotropy and inotropy (data not shown).
Fig. 1 – Oliveira-Monteiro et al. 2011 BJP
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Figure 18. Protein kinase C (PKC) is modulated by A1R. Concentration-response curves of R-PIA (A and B) and
oxotremorine (C and D) in the absence (Control) or in the presence of the PKC inhibitor, chelerythrine (3 µM). R-PIA (0.001-
1 µM) (A and B) and oxotremorine (0.01-3 µM) (C and D) were applied once every 2 min at increasing concentrations.
Chelerythrine was added to the incubation fluid 15 minutes before application of agonists. The ordinates are percentage of
variation of spontaneous contraction rate (chronotropic effect, A and C) and mechanical tension (inotropic effect, B and D)
as compared to baseline values obtained before application of R-PIA or oxotremorine. The data are expressed as mean ±
SEM from an n number of individual experiments. *P<0.05 compared with the effect of agonists in the absence of PKC
inhibitor.
PKC activity has been associated to myofilament Ca2+ sensitization and
phosphorylation of TnI and cardiac myosin binding protein-C promote a positive inotropic
effect (Cazorla et al., 2009). This mechanism may add another possible explanation for
the preferential chronoselective action of ADO in the rat spontaneously beating atria.
Enrolment of the PLCβ/PKC signaling cascade pathway triggered by A1R activation
partially counteracts the negative inotropic effect of the nucleoside that one would expect
by simply hyperpolarizing atrial cardiomyocytes and, thereby, decreasing intracellular Ca2+
accumulation. Unraveling these complexities requires further experimental work.
Unexpectedly, non-specific activation of PKC with the phorbol 12-myristate 13-acetate,
PMA (0.03-10 µM) (Puceat and Vassort, 1996), concentration-dependently increased
sinus rate reaching a maximum at 10 µM (+11±3%, P<0.05; n=11), yet no effect was
observed in the strength of contractions of the spontaneously beating rat atria (P>0.05;
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n=11, data not shown). Pre-incubation of the preparations with PMA (10 µM, for 15
minutes) did not significantly (P>0.05) change R-PIA (0.001-1 µM) and oxotremorine
(0.01-3 µM) atrial depression (Figure 19).
Figure 19. PKC activation failed to modify the effects of A1R and M2R. Concentration-response curves of R-PIA (A and B)
and oxotremorine (C and D) in the absence (Control) or in the presence of the PKC activator, PMA (10 µM). R-PIA (0.001-1
µM) (A and B) and oxotremorine (0.01-3 µM) (C and D) were applied once every 2 min at increasing concentrations. PMA
was added to the incubation fluid 15 minutes before application of agonists. The ordinates are percentage of variation of
spontaneous contraction rate (chronotropic effect, A and C) and mechanical tension (inotropic effect, B and D) as compared
to baseline values obtained before application of R-PIA or oxotremorine. The data are expressed as mean ± SEM from an n
number of individual experiments. *P<0.05 compared with the effect of agonists in the absence of PKC activator.
In spite of these unexpected results, we cannot rule out the participation of PKC in
A1R-mediated atrial depression, since PMA acts as a non-selective activator of PKC
leading to enzyme desensitization. Furthermore, growing evidence points towards specific
activation and translocation of some PKC isozymes secondary to A1R activation (Lester
and Hofmann, 2000; Yang et al., 2009b). In order to avoid non-selective activation of PKC
by PMA, we performed experiments with two G-protein-coupled neurohormonal agents
known to couple positively to the PLC/PKC pathway via the Gαq subunit (Puceat and
Vassort, 1996). This was carried out by using angiotensin II (AngII), as an AT1 receptor
agonist considering its ability to engage specifically the activation of novel PKCs isoforms
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(PKC-ε and PKC-δ) (Kilts et al., 2005), and UTP, as an activator of cardiac P2Y2 and P2Y4
receptors coupled to Gαq subunits.
Figure 20. Gαq protein-coupled receptors (AT1 and P2Y2,4 receptors) did not interfere with signaling properties of both A1R
and M2R. Left panels (A, B, E and F) are plotted concentration-related chronotropic for R-PIA (A and B) and for
oxotremorine (E and F) in the absence (Control) or in the presence of AngII (A and E) or UTP (B and F). Right panels (C, D,
G and H) are plotted concentration-related inotropic for R-PIA (C and D) and for oxotremorine (G and H) in the absence
(Control) or in the presence of AngII (C and G) or UTP (D and H). R-PIA (0.001-1 µM) and oxotremorine (0.01-3 µM) were
applied once every 2 min at increasing concentrations; AT1 and P2Y2,4 agonists, Ang II (125 nM) and UTP (100 µM),
respectively, were added to the incubation fluid 15 minutes before application of R-PIA or oxotremorine. The ordinates are
percentage of variation of spontaneous contraction rate (chronotropic effect, left panels) and mechanical tension (inotropic
effect, right panels) as compared to baseline values obtained before application of R-PIA or oxotremorine. The data are
expressed as mean ± SEM from an n number of individual experiments.*P<0.05 is considered statistically different
compared with the corresponding control curve for each agonist.
As expected, AngII (125 nM) developed statistically significant positive inotropic
(+8±3%, P<0.05; n=8) and chronotropic (+10±3%, P<0.05; n=8) responses (data not
shown) (Li et al., 1996). On the other hand, UTP (100 μM) did not significantly change the
sinoatrial rate (P>0.05), although it mildly increase the atrial inotropy (+17±4%, P<0.001;
n=14) (data not shown). Pre-incubation with AngII (125 nM) or UTP (100 µM) did not
significantly modify the effects of R-PIA (0.001-1 µM) and oxotremorine (0.01-3 µM) in the
rat spontaneously beating atria (Figure 20).
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IV. Discussion
In the present work we evaluated the effects of two well-know neurohormonal
agents ADO and ACh on the spontaneously beating rat atria. ADO and ACh analogues
exerted pronounced negative chronotropic and inotropic effects (Figure 6) respectively
through A1AR and M2R (De Biasi et al., 1989; Kohl et al., 1990; Ford and Broadley, 1999).
Interestingly, the negative chronotropic effect of A1R activation was evidenced at much
lower concentrations (~30 fold) than the negative inotropic effect. The ADO
chronoselective effect was a singular hallmark of A1R, since the M2R agonist oxotremorine
was equipotent upon reducing chronotropy and inotropy (Figure 6). So, we first
investigated whether A1R chronoselectivity could be an outcome of a higher expression of
this receptor in the SA node than in the atrial muscle. We observed that A1R and M2R are
abundantly expressed in rat atria, as previously described (Krejci and Tucek, 2002;
Myslivecek et al., 2008; Chandler et al., 2009) (Figure 8). Immunolocalization experiments
did not reveal any noticeable difference regarding the A1R staining across the entire right
atria, as it was observed for the M2R (Chandler et al., 2009; Yanni et al., 2011). These
observations suggest that the chronoselectivity induced by A1R stimulation is not
supported by a differential expression of this receptor within the atrial tissue in particular
the SA node, strengthening the hypothesis that other mechanisms must be involved.
Additionally, we further speculated on whether ADO chronoselectivity could hold
an A2AR-mediated component. The selective A2AR agonist, CGS 21680, revealed a
negligible positive inotropy at higher concentrations (Chandrasekera et al., 2010).
Although, A2AR was found to be expressed in mammalian atria (Hove-Madsen et al.,
2006), we found low levels of immunofluorescence representation of this receptor at the
rat atria as compared to the A1R (Figure 9). While the role of A2AR in cardiac inotropism is
still a matter of debate, some authors argue that A2AR activation can increase the
sensitivity of the contractile apparatus (Hove-Madsen et al., 2006), thereby enhancing
myocardial contraction (Dobson and Fenton, 1997; Monahan et al., 2000; Tikh et al.,
2006). Conversely, other authors failed to detect positive inotropic effects after A2AR
stimulation (Willems and Headrick, 2007; Gergs et al., 2009; Chandrasekera et al., 2010).
These contradictory data support the hypothesis that A2AR only plays a role in the
modulation of the β-adrenergic action rather than a direct effect on cardiac inotropism
(Tikh et al., 2006; Fenton et al., 2009; Chandrasekera et al., 2010).
It is well-known that A1R and M2R stimulate outward K+ currents (IKAdo,ACh) through
Gβγ subunits activation of G protein-coupled inwardly rectifying (tertiapin Q-sensitive)
GIRK/KIR3.1/3.4 channels (Kurachi et al., 1986; Logothetis et al., 1987; Krapivinsky et al.,
1995; Han and Bolter, 2011). This action reduces the electrogenic current carried by ion
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channel/exchangers involved in the diastolic depolarization (phase 4) and speeds up the
AP repolarization phase. The overall effect of this GIRK/KIR3 current is a decreased
excitability of the SA nodal cells, i.e. negative chronotropy. Faster AP repolarization
(phase 3) also reduces the time available for Ca2+ influx during phase 2 of the AP, thereby
putatively reducing atrial inotropism (Kurachi et al., 1986; Wang and Belardinelli, 1994;
Belardinelli et al., 1995; Lyashkov et al., 2009). Taking into account that all experiments
described herein were carried out in the absence of electrical pacing or adrenergic
stimulation, the effects operated by A1R and M2R activation are likely to be mediated
directly by GIRK/KIR3 opening, as proven by the attenuation of the cardiodepressant
effects of A1R and M2R agonist upon inhibition of these channels with tertiapin-Q. It is
worth noting that GIRK1/KIR3.1channel subunits are expressed throughout the rat atria, in
both the SA node and the atrial cardiomyocytes, as detected by immunofluorescence
confocal laser microscopy in this study (Figure 10), which confirmed other authors’
findings (Dobrzynski et al., 2001; Chandler et al., 2009; Yanni et al., 2011).
We further investigated the role of other ionic channels on A1R- and M2R-elicited
responses, in order to explore if they were functionally coupled to A1R, but not to M2R,
which could justify the preferential A1R-mediated chronoselective atrial depressant effect.
Among the channel blockers tested in this study, namely verapamil (a CaV1 (L-type)
channel blocker), mibefradil (a low voltage-activated CaV3 (T-type) channel blocker), 4-
aminopyridine (a non-specific voltage-dependent Kv channel blocker), glibenclamide (a
selective ATP-sensitive KATP/KIR6 channel blocker) and apamin (a KCa2/SK channel
blocker), only verapamil and apamin selectively affected the contractile responses elicited
by A1R activation, which put forward the putative enrollment of CaV1 (L-type) and SK/KCa2
channels on ADO chronoselectivity. Our results are in general agreement with previous
isometric contraction studies performed in the guinea-pig atria, where 4-AP (0.3-3 mM)
failed to modify chronotropic and inotropic effects elicited by increasing concentrations of
R-PIA (De Biasi et al., 1989). Conversely, other authors reported the ability of 4-AP to
counteract the negative chronotropic and inotropic effects of M2 and A1 receptor agonists
in atrial preparations (Urquhart and Broadley, 1991; Ford and Broadley, 1999). Due to the
high concentrations of 4-AP used in the latter studies, which were 1000 times higher than
that used in this report (10 µM), a question remains unanswered about the Kv channel
selectivity of the 4-AP blocking effect under those circumstances. Regarding
glibenclamide-sensitive K+ channels, some authors connected its opening to protective
effects of ADO under conditions of low oxygen tension (e.g. ischemia, hypoxia) (Kirsch et
al., 1990). However, under well-oxygenated conditions, high levels of ATP tonically
inhibits ATP-sensitive KATP/KIR6 channel opening, explaining the lack of effect of
glibenclamide in antagonizing the responses to M2 and A1 receptor agonists in the rat
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atria, in good agreement with previous studies (Keith and Flack, 1907; Urquhart et al.,
1993; Ford and Broadley, 1999). Beyond these K+ currents, Ca2+ current carried by CaV3
(T-type) channel is excluded from adenosinergic as well as cholinergic regulation of atrial
function (Cerbai et al., 1988).
The leftward displacement of the concentration-response curve regarding the
inotropic effect of R-PIA upon blocking CaV1 (L-type) channels (with verapamil) has two
reasonable interpretations: 1) A1R stimulation inhibits CaV1 (L-type) channels that is
further potentiated by CaV1 (L-type) channels blockade, or 2) under basal conditions, A1R
stimulation decreases to a lesser extent the net Ca2+ entry into atrial myocytes when
compared to M2R, attenuating the cardiodepressor effect promoted by opening of
GIRK/KIR3 channels.
The first explanation is somehow controversial; there are no clear evidences that
Gαi-coupled receptors, such as A1R and M2R, decrease directly the CaV1 (L-type)
channels, although some authors detected a small inhibitory actions of adenosinergic and
cholinergic agonists on this currents (Cerbai et al., 1988; De Biasi et al., 1989; Visentin et
al., 1990). Recent experimental data also proposed an inhibition of ICa,L currents in the
course of releasing Gβγ subunits from activated Gαi/o-coupled receptors (O-Uchi et al.,
2008). Conversely, in guinea pig atrial myocytes, ADO did not show any significant
changes on ICa,L, in the presence of its activator BAY K 8644 (Wang and Belardinelli,
1994).CaV1 (L-type) channels inhibition operated by A1R and M2R activation may, most
probably, be an indirect effect, considering that GIRK/KIR3 opening shortens AP duration
and reduces the time available for the influx of Ca2+ (Iijima et al., 1985; Wang and
Belardinelli, 1994; Belardinelli et al., 1995; Ford and Broadley, 1999).
The second hypothesis fits our data if we take into consideration a presumable
interaction between A1R and apamin-sensitive SK/KCa2 channels (Figure 13). SK/KCa2
channels behave like truly intracellular Ca2+ sensors by changing their K+ conductance
and membrane resting potential. At least three types of ion channels may participate in
this mechanism, namely SK1/KCa2.1, SK2/KCa2.2 and SK3/KCa2.3. These channels exhibit
weak-voltage dependence, differences in Ca2+-dependent activation and variable
sensitivity to apamin (Ishii et al., 1997; Xu et al., 2003; Tuteja et al., 2005). Interestingly,
the concentration-response curve for the negative inotropic effect of R-PIA was
significantly modified upon blockade of SK/KCa2 channels with apamin, without affecting
the effect of oxotremorine. This renders a functional crosstalk between A1R and SK/KCa2
channels on inotropy, highly probable. This experimental result therefore challenges
previous assumption that A1R function is insensitive to SK/KCa2 channels blockade in the
guinea-pig atria (De Biasi et al., 1989). Sensitization of rat atria to the negative inotropic
effect of the A1R agonist in the presence of the SK/KCa2 channel blocker affords a
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functional role for these channels on E-C coupling mechanisms. Blockade of SK/KCa2
channels may cause a delay in the repolarization phase of atrial APs (Xu et al., 2003;
Tuteja et al., 2005), despite of Nagy and co-workers have failed to detect any
electrophysiological change upon apamin exposure (Nagy et al., 2009). In our hands,
blockade of SK/KCa2 channels caused per se a slight increase in the strength of
contraction, which might be related to an increase in the available time for Ca2+ influx via
CaV1 (L-type) channels due to AP prolongation. Interestingly, CaV1 (L-type) channels are
sought to be functionally coupled to SK2/KCa2.2 channels, sharing the same cytoskeletal
protein α-actinin2 (Lu et al., 2007). Even more interestingly, these authors showed that
this multiprotein complex formed by SK2/KCa2.2, CaV1 (L-type) channel and α-actinin2 is
located in cardiac t-tubules, where the functional units of the cardiac E-C coupling are
located, reinforcing the importance of a hypothetical regulation of CaV1 (L-type) channels
gating by SK/KCa2 channels operation, with important outcomes on inotropy regulation
(Bers, 2002; Catterall, 2011). Thus, a possible explanation for ADO chronoselectivity is
that A1R partially inhibits SK/KCa2 channel, decreasing the voltage- and time-dependent
inactivation of CaV1 (L-type) channels during AP repolarization phase, leading to a lesser
net decrease of Ca2+ influx into atrial myocytes during A1R (vs M2R) stimulation (Xu et al.,
2003; Tuteja et al., 2005).
Despite being an attractive hypothesis, at this moment there is no clear evidence
that supports inhibition SK/KCa2 channels by A1R activation. Keeping in mind this
hypothetical scenario, it would be expected a higher activity of inward currents, like ICa,L,
during pharmacological inhibition of SK/KCa2 channels and, thus, a rightward
displacement of the inotropic concentration-response curve for R-PIA. Of note is that our
experimental procedure to evaluate inotropy is based on variations of the contractile
tension that might reflect Ca2+ influx from CaV1 (L-type) channels (Bers, 2002). Therefore,
the leftward displacement of the inotropic concentration-curve for R-PIA with either
SK/KCa2 or CaV1 (L-type) channels blockade might be interpreted as a relative increase of
GIRK/KIR3-mediated K+ efflux and cell hyperpolarization per GPCR activated, thus
affecting the relative potency of the A1R agonist. As mentioned above, a greater
contribution of GIRK/KIR3-mediated K+ efflux will shorten much more the atrial APs,
thereby reducing even more the Ca2+ influx through CaV1 (L-type) channels (Iijima et al.,
1985; Wang and Belardinelli, 1994; Belardinelli et al., 1995). We believe that SK/KCa2
channels should only have a modulator role on A1R-mediated responses, since apamin
per se did not have a meaningful effect on inotropy. Interestingly, a recent report has
demonstrated an interaction between A1R and SK/KCa2 channels in retinal ganglion cells,
which was dependent on IP3-induced Ca2+ release from internal stores, even though it has
been concluded that SK/KCa2 channel opens in response to A1R activation (Clark et al.,
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2009). Despite SK/KCa2 channels expression in the SA node (Figure 15), their blockade
did neither affected spontaneous AP firing rate under basal conditions nor the
chronotropic concentration-response curves for R-PIA and oxotremorine (Figures 13 and
14), which might suggest a non-functional role on chronotropy regulation, at least in
healthy and adult heart mammals. As presented in Figure 15, both SK2/KCa2.2 and
SK3/KCa2.3 are both present throughout the right atria, despite their dissimilar labeling
pattern. The SK2/KCa2.2 channels are mainly present around the myocytes, even though
some authors have showed a t-tubule location (Lu et al., 2007). SK3/KCa2.3 showed an
internal labeling pattern and lower immunoreactivity in atrial myocytes as observed by
others (Tuteja et al., 2005). However, myocytes of the SA nodal showed a high level of
staining using anti-SK3/KCa2.3 antibody when compared to surrounding tissue, compatible
with the differential abundance of SK3/KCa2.3 transcripts within the rat atria (Yanni et al.,
2011). It is worth of notice that the abundance of SK1/KCa2.1 and SK3/KCa2.3 channels,
but not SK2/KCa2.2 channel, was greatly increased in the SA node during heart failure
(Yanni et al., 2011). The physiological importance of these regional differences for
SK/KCa2 channels has yet to be determined.
Immunofluorescence micrographs (Figure 15) confirmed the presence of
verapamil and apamin-sensitive channels and support the pharmacological data elicited
by these two blockers. Immunofluorescence analysis exhibited weaker immunoreactivity
intensity for the extracellular α2δ-1 subunit of the CaV1 (L-type) channels. In studies
performed in the right atrium of either human or rat heart, the accessory α2δ-1 subunit was
found equally expressed between SA node and atrial muscle (Chandler et al., 2009; Yanni
et al., 2011). From the analysis of these two studies we can argue that accessory subunit
of CaV1 (L-type) channel is relatively high expressed in mammal’s right atrium and there is
no clear relation with the expression of each CaV1 (L-type) channels pore-forming α
subunit (α1C and α1D). CaV1 (L-type) α1C subunit (CaV1.2) is much more expressed in atrial
muscle than in SA node of adult mammals, while the CaV1 (L-type) channels α1D (CaV1.3)
subunit has an opposite expression pattern (Tellez et al., 2006; Chandler et al., 2009;
Allah et al., 2011). Here, despite the unexpected low immunoreactivity for CaV1 (L-type)
channels α2δ subunits, the absence of its differential expression between SA node and
atrial muscle matches with reported experimental data regarding α2δ-1 subunit
expression. At the best of our knowledge, this is the first study designed to analyze the
CaV1 (L-type) α2δ-1 subunit expression in the mammalian heart by confocal microscopy.
Other putative explanation for ADO chronoselectivity was brought to light from
recent studies on the molecular signaling dynamics and compartmentalization of the
receptors and channels in sarcolemma microdomais, like caveolae. Here, we showed that
A1R-mediated responses are somehow linked to the PLCβ-PKC pathway, in opposition to
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M2R responses (Figure 16 and 18). A1R and M2R are both Gαi-coupled receptors and their
activation leads to dissociation of the Gβγ dimer. Since free Gβγ subunits may stimulate
PLCβ (Boyer et al., 1992), one might predict that the M2R-mediated effects would be also
sensitive to inhibition of PLCβ by U73122, as it happened with the negative inotropic
response elicited by A1R activation (Figure 16). Therefore, following A1R activation we
should expect increases in PLCβ end products, such as IP3 and diacylglycerol (Nishizuka,
1992). Overwhelming experimental data demonstrated that A1R agonists increase the
levels of both IP3 and DAG in a large variety of cell types (Kohl et al., 1990; Gerwins and
Fredholm, 1992; Dickenson and Hill, 1998; Cordeaux et al., 2000; Lester and Hofmann,
2000; Parsons et al., 2000; Fenton et al., 2010). Although we did not measure IP3 and
DAG levels, data obtained with the PLC inhibitor applied prior to stepwise addition of R-
PIA significantly sensitized atria to the negative inotropic effect of A1R and removed ADO
chronoselectivity. But how does PLCβ attenuate the inotropic depressor effect of A1R? To
answer this question we need to go back and look carefully to the concentration-
responses curves of R-PIA in the absence and presence of tertiapin-Q (Figure 10). When
GIRK/KIR3 channels were blocked, spontaneous atrial beatings did not stop neither atrial
contractile tension was reduced during stimulation of both cholinergic and ADO receptors.
Thus, regarding GIRK/KIR3 channels one may argue that they might play an important role
on E-C coupling from supraventricular tissues during cholinergic and adenosinergic
stimuli, and their opening mediates a negative inotropic response (Iijima et al., 1985;
Wang and Belardinelli, 1994; Belardinelli et al., 1995; Ford and Broadley, 1999). The
relation between GIRK/KIR3 channels and PLCβ activity come up from the well-accepted
PIP2 role on GIRK/KIR3 channel gating (Whorton and MacKinnon, 2011).
ADO and ACh stimulate GIRK/KIR3 channels opening but with different magnitudes
and kinetics (Kurachi et al., 1986; Cho, 2010; Littwitz et al., 2011). In atrial myocytes both
the onset kinetics and the total GIRK/KIR3 current activated by supramaximal
concentrations of ADO (> 10 µM) (IK,ADO) are slower and of a lesser magnitude than those
obtained with ACh (> 10 µM) (IK,ACh) (Cho, 2010). Besides that, IK,ADO is more sensitive to
Gαq-coupled receptor modulation (e.g. α1-adrenoceptors) than IK,ACh (Cho, 2010; Cui et al.,
2010). As claimed in these authors’ studies, PIP2 signaling microdomain and caveolar
receptor compartmentalization might be the basis for the differential receptor-mediated
activation and regulation of GIRK/KIR3 channels. PIP2 is needed for GIRK/KIR3 channels
opening and its catabolism inhibits the hyperpolarizing K+ current (Kobrinsky et al., 2000).
Interestingly, using neomycin as a measure of PIP2 affinity, M2R-activated GIRK/KIR3
current showed higher affinity for PIP2 than the ones elicited by A1R activation (Cho,
2010). Comparatively IK,ACh is a stronger current with a lesser sensitivity to PIP2
perturbation than IK,ADO, at least in mouse atrial myocytes (Cho, 2010; Cui et al., 2010). If
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we take into consideration that the A1R-activated GIRK/KIR3 current is weaker, along with
the putative A1R-mediated PIP2 hydrolysis, it may be reasonable to assume that the lesser
A1R-mediated contractile depression compared to M2R activation might be a consequence
of the limited negative inotropy when GIRK/KIR3 couples do  A1R activation. Consistent
with this theory, inhibition of PLCβ with U73122 protected PIP2 from A1R -mediated
hydrolysis and enhanced GIRK/KIR3 channels activity, which in turns potentiates the
negative inotropy (Figure 16). In this context there seems to be a spatiotemporal
regulation of PIP2 signaling within caveolae that connects receptor function to ionic
channel currents. A1R stimulation might, therefore, have a less impact on negative
inotropy probably because this receptor recruits signaling machinery to caveolae where
GIRK/KIR3 channels are located, stimulating GIRK/KIR3 channel activation followed by its
inactivation, whereas M2R lack this effect. Lesser K+ conductance carried by GIRK/KIR3
channel conductance mirrors smaller voltage- and time-dependent inactivation of CaV1 (L-
type) channels located in the t-tubules that, in a final step, yields a lesser reduction of net
Ca2+ influx into atrial myocytes as compared to M2R. It is worth mentioning the lower
chronotropic sensitivity to PLC inhibition (Figure 16A and C), demonstrating that the
control of spontaneous generation of pacemaker AP is not so sensitive to GIRK/KIR3
channel modulation as atrial myocytes, and might involve other key mechanisms in
adenosinergic and cholinergic depression (Wickman et al., 1998; Vinogradova et al.,
2006; Lyashkov et al., 2009).
Nevertheless, the previous theory proposed for ADO chronoselectivity may not rely
solely on the reorganization of signaling proteins and lipids within caveolae. We need to
go beyond sarcolemma microdomains and look to downstream targets of PLCβ. There is
growing evidence for an increase of DAG and IP3 from PIP2 hydrolysis following A1R
stimulation (Kohl et al., 1990; Gerwins and Fredholm, 1992; Dickenson and Hill, 1998;
Cordeaux et al., 2000; Lester and Hofmann, 2000; Parsons et al., 2000; Fenton et al.,
2010). For example, after specific A1R activation, a meaningful increase of inositol
phosphates and DAG levels has been observed in cultured chick embryo ventricular
myocytes, which was attenuated by the PLC inhibitor U73122 (10 µM) (Parsons et al.,
2000). Other studies also detected a Gβγ-dependent increase of IP3 levels following A1R
stimulation in mouse heart myocytes (Fenton et al., 2010). Even though it was not
expected an outstanding modulation of PLCβ by A1R, as observed with stimulation of
other Gαq-coupled receptors (e.g. odd-numbered muscarinic receptors, AT1 receptors),
because Gβγ subunits are less potent activators of PLC compared with G protein αq
subunits (Boyer et al., 1992; Biber et al., 1997). Positive chronotropic and inotropic effects
are connected to Gαq proteins-coupled receptor stimulation (He et al., 2000; Lipp et al.,
2000; Bers, 2002; O-Uchi et al., 2008; Ju et al., 2011).
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Multiple analysis of IP3 receptors revealed higher expression and function of
subtype II in atrial myocytes than in ventricular ones (about 6-fold) together with a
subsarcolemmal location near junctional RyRs (Lipp et al., 2000). IP3 formation induces
Ca2+ release from internal stores (Berridge, 1993). Thus, in supraventricular tissues IP3
enables stimulating effects on atrial E-C coupling (Lipp et al., 2000; Bers, 2002). With
respect to our results, the contractile depression observed with PLC inhibition during A1R
stimulation (Figure 16) might also be interpreted as a blunted PLC-mediated positive
stimulus. Positive inotropic responses following A1R stimulation were also observed in
other reports (Neumann et al., 1999; Gergs et al., 2009). The present results implies a
direct cross-talk between A1R and PLCβ (Fenton et al., 2010), which may increase IP3-
induced Ca2+ release from intracellular stores (Berridge, 1993) attenuating the negative
inotropy mediated through GIRK/KIR3-mediated K+ efflux.
The supposed connection between ADO chronoselectivity and the A1R-induced
IP3 increase could not be addressed in our experimental model because 2-APB (30 µM),
an IP3 receptor blocker (Maruyama et al., 1997), blocked the spontaneous atrial
contractions (Figure 17). This result means that there is a basal and critical activity for IP3
receptors on the spontaneous generation of AP at the SA node. In fact, several reports
argue in favor of a relevant function of IP3R on cardiac pacemaker activity (Ju et al.,
2011). However, we cannot exclude the lack of pharmacological selectivity by 2-APB on
other critical pacemaker components. The proposed mechanism for 2-APB was the
inhibition of SERCA pump, leading to a progressive depletion of Ca2+ stores followed by
an E-C coupling impairment (Peppiatt et al., 2003).
Moving towards downstream targets of the PLCβ generated products, we explored
the role of PKC on both A1R- and M2R-mediated responses. Inhibition of PKC with
chelerythrine significantly potentiated the negative inotropy mediated by A1R activation
with no appreciable effects on the negative chronotropy (Figures 18A and B). Surprisingly,
PKC inhibition did not affect both chronotropy and inotropy effects of M2R stimulation
(Figures 18C and D), unveiling another signal transduction disparity between the A1R and
M2R signaling. The role of PKC in A1R-mediated responses is not surprisingly since PLCβ
is an effector of the ADO signaling pathway, providing stimuli input for PKC activation
through DAG formation and IP3-dependent Ca2+ release (Parsons et al., 2000; Fenton et
al., 2010). Indeed, there are numerous reports supporting the existence of PKC and A1R
crosstalk in a wide variety of responses like in adrenoprotection (Lester and Hofmann,
2000; Fenton et al., 2009; Fenton et al., 2010). According to our results, there is a clear
tendency for PKC counteracting the A1R-mediated contractile depression. Therefore, it
would be expected a positive inotropic effect upon atria exposure to increasing
concentration of the PKC activator, PMA. Unexpectedly, the concentration-response curve
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of PMA, as well as the direct application of PMA (10 µM) for 15 min, did not show any
considerable effect on atrial contraction force and only a minor positive chronotropy was
observed (data not shown). Moreover, PMA was not able to modify both inotropic and
chronotropic curves for A1R as well as for M2R stimulation (Figure 19).
PKC has a broad-spectrum of substrates that comprises ionic channels,
myofilaments, and even kinases (Puceat and Vassort, 1996; Kamp and Hell, 2000;
Solaro, 2008; Yang et al., 2009a), but there is no consensus in the scientific community
about the functional effects of PKC on heart function. While some authors ascribe positive
inotropic effects for PKC others allocate negative or no effects (Capogrossi et al., 1990;
MacLeod and Harding, 1991; Karmazyn and Haist, 1993). Even more intriguing about
PKC is the fact that a wide variety of positive inotropic mechanisms are usually dependent
on PKC function (He et al., 2000; Kilts et al., 2005; O-Uchi et al., 2008; Cazorla et al.,
2009; Oestreich et al., 2009). An explanation for these controversies around PKC could
rely on broadly activation of several PKC isozymes due to lack of selective drugs, in
contrast to neurohormonal agonists; animal species and their development stage; time,
type, concentration and even in the mode of PKC-targeted drugs administration
(Karmazyn and Haist, 1993; Puceat and Vassort, 1996; He et al., 2000).
Rather than a non-selective activation of PKC isozymes, A1R signaling has been
connected to selective activation of PKC-ε and PKC-δ isozymes, which are the major
Ca2+-independent and the most abundant PKC isoforms found in adult rat cardiomyocytes
(Yang et al., 2009b). However, while the selective activation, translocation and anchoring
of PKC isozymes to specific subcellular locations is undoubtedly important for ADO
signaling, it remains to be elucidated how this is accomplished and what are the functional
effects on heart’s function. Concerning cardiac contractile function, some reports describe
PKC-ε as a negative effector of A1R-mediated cardiodepression (Lester and Hofmann,
2000; Fenton et al., 2009; Fenton et al., 2010). Conversely, other studies regarding
functional effects of PKC-ε have challenged the above mentioned PKC-ε-mediated
negative effect (Kang and Walker, 2005; Kilts et al., 2005; O-Uchi et al., 2008). Myocytes
overexpressing either PKC-ε or PKC-δ react to PKC activator phorbol 12,13-dibutyrate
(PDBu) developing a short negative followed by a sustained positive inotropic response,
i.e. biphasic response, while control myocytes only developed negative responses.
Interestingly, pharmacological maneuvers selectively targeted to Ca2+-dependent PKC
isoforms inhibition (Gö 6976, 1 µM) only removed negative inotropic responses elicited by
phorbol esters, which suggests an involvement of conventional (e.g. α, β) and novel PKCs
(e.g. ε, δ) on the negative and positive inotropic responses, respectively (Kang and
Walker, 2005), in good agreement with recent reports (Kilts et al., 2005; O-Uchi et al.,
2008; Liu et al., 2009). Thus, PKC isoforms are likely to have different or even opposing
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effects on heart muscle contractility; hence, the non-selective PKC activation (Yang et al.,
2009b) may explain the absence of effect observed with PMA (Figure 19). It is worth
noting that PMA is a broad spectrum activator of PKC and that property could mask the
involvement of some PKC isoforms on A1R-mediated effects. To overcome the lack of
specificity by PMA in PKC activation, we employ UTP and AngII as neurohormonal agents
known for their action on Gαq-coupled receptors (Puceat and Vassort, 1996; Kilts et al.,
2005). Unfortunately, previous activation of the downstream Gαq-coupled receptors
pathways either with AngII or UTP failed to change the typical atrial effects produced by
A1 and M2 agonists (Figure 20). However, we should not rule the hypothetical connection
between A1R and PKC, since the experimental approach used in this work might not be
suitable to unveil this crosstalk. Our results point to an interplay of PKC with the A1R
(Figure 18), but further investigations are needed to clearly understand what is behind the
chronoselective effect.
At this moment, limited conclusions are available regarding the effects of PKC
isozyme(s) in the regulation of contractile force (Puceat and Vassort, 1996). For those
who support a negative contractile response, a decrease in myofilament Ca2+ sensitivity
and cross-bridge cycling, is a likely explanation (Lester and Hofmann, 2000; Solaro, 2008;
Fenton et al., 2009), while for the others modulation of Ca2+-handling proteins (e.g.
phospholamban, CaV1 (L-type) channels, RyR) and myofilament Ca2+ sensitization are on
the basis of positive inotropic responses (He et al., 2000; Kang and Walker, 2005; Wang
et al., 2006; Cazorla et al., 2009; Oestreich et al., 2009).
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V. Conclusion
In conclusion, we demonstrated that atrial chronoselectivity observed for ADO
A1R-mediated responses is not supported by a higher expression of A1R in the SA node
as compared to the atrial muscle. The matchless chronoselectivity for A1R, observed in
the spontaneously beating rat atria, may yield from the molecular enrolment of A1R with
SK/KCa2 and CaV1 (L-type) channels, a PLC and downstream effectors as well.
At the mechanistic level, we showed that contractile depression triggered by A1R
and M2R activation are mostly restricted to K+ efflux through GIRK/KIR3 channels opening,
especially when atria are not under sympathetic influence. Given the pivotal role of PIP2
on GIRK/KIR3 channel gating (Kobrinsky et al., 2000; Whorton and MacKinnon, 2011), any
perturbation in the steady-state PIP2 levels may lastly interfere with GIRK/KIR3-regulated
atrial contraction. In fact, our study provides strong evidences that the membrane-
restricted PIP2 signaling could be modulated by A1R. Both A1R and M2R activate
GIRK/KIR3 channel, in a Gβγ- dependent manner. However, since K+ current carried by
GIRK/KIR3 channels upon A1R stimulation is much more sensitive to PIP2 perturbation, the
proposed A1R-mediated stimulation of PLCβ activity may decrease PIP2 levels within
sarcolemmal microdomais where GIRK/KIR3 channels are located, then promoting
GIRK/KIR3 channel deactivation along with a less GIRK/KIR3-mediated contractile
depression, at least in comparison to M2R (Figure 21). The interplay of A1R with PLCβ
may also trigger SR Ca2+ release through generation of IP3 (Berridge, 1993) that should
attenuate negative inotropy, but this remains a speculative assumption since our
experimental approach does not prove it.
Beside GIRK/KIR3 channels, our functional experiments go in line with a restrained
SK/KCa2 channel operation during A1R stimulation that greatly affects the atrial inotropic
status. Inhibition of repolarizing K+ currents during AP repolarization phase, like K+
currents carried by GIRK/KIR3 and SK/KCa2 channels should in a final step interfere with
Ca2+ dynamics that drive E-C coupling in atrial myocytes. These channels can be
regarded as gatekeepers of cellular excitability readily to be recruited during stressful
conditions. If these repolarizing K+ currents shorten AP, thereby obviating time course for
Ca2+ influx (Iijima et al., 1985; Capogrossi et al., 1990; Wang and Belardinelli, 1994;
Belardinelli et al., 1995), it is reasonable to assume that the contrary is true for the
proposed inhibition of these currents upon A1R activation. Thus, negative inotropism of
A1R holds a compensatory contractile mechanism comprised by K+ channels inhibition
and, consequently, longer times for Ca2+ entry into atrial myocytes. Unlike atrial muscle
cells, SA nodal cells seem to be tougher to modulation of SK/KCa2 gating and PLCβ/PKC
axis. Hence, in SA nodal cells the depressor balance supplied by these signaling proteins
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might not be relevant for A1R chronotropic regulation, explaining why A1R act as
chronoselective atrial depressant effector (Figure 16 and 18). Of note, our research also
demonstrated that PKC function impairment sensitizes atria for contractile depression
during graded increase of adenosinergic stimuli. It is hard to establish a solid and
coherent connection among A1R, PKC and chronoselectivity because, at the best of our
knowledge, no one has provided evidences strong enough to rule out the doubtfulness
around the role of PKC isozymes on regulation of myofilament properties and other
components of the EC-coupling mechanism, like CaV1 (L-type) channels.
Finally, these data also reinforces the dissimilarity between the signaling of A1R
and M2R on heart function regulation, also supported by the fact that ACh did not modify
atrial cardiodepression, as observed with A1R agonists (data not shown). Looking at atrial
regulation as an integrative process of several neural and non-neural mechanisms,
activation of cardiac M2R is under hierarchical control of ACh releasing mechanisms from
the vagus nerve terminals while ADO releasing mechanisms are naturally less controlled.
In other words, the subordinate neurotransmitter of the parasympathetic nervous system
offer a strong control of cardiac output by changing with similar potency heart rate and
inotropy (stroke volume depends on atrial inotropy). Conversely, retaliatory ADO is
brought to the extracellular medium by neural and non-neural mechanisms during
stressful conditions and therefore, not so tightly regulated as ACh release. If ADO shared
the same pattern of cardiodepression as ACh, large amounts of this nucleoside released
during low oxygen tension (Sparks and Bardenheuer, 1986; Deussen, 2000) would be
much more life-threatening than it really is. Thus, and according to the results of the
current study, it could be suggested that the safety margin of these two cardiodepressor
agents is provided by meticulous neural mechanisms (for ACh) and by the
chronoselective property of the A1R itself (for ADO).
From a clinical point of view, the selective heart rate-reducing induced by ADO
may be advantageous to protect hearts from deleterious effects of tachycardias and
metabolic compromised states (e.g. hypoxia, ischemia, higher sympathetic tonus), in
particular in those hearts with ventricular myocardial dysfunction (e.g. heart failure) where
excessive atrial cardiodepression could be life-threatening. The overall effect of ADO
outflow to the extracellular medium during metabolic challenge, or intravenous bolus
administration of these nucleoside/derivates, is reoxygenation of the myocardium since
energy expenditure is reduced by a decrease of heart rate and oxygen consumption (via
A1R) and rise of myocardial oxygen-supply by coronary dilation (via A2R) (Shryock and
Belardinelli, 1997; Headrick et al., 2011). The cytoprotector and antidysrhythmic profile of
this endogenous nucleoside and its derivates (e.g. tecadenoson) are not accomplished at
the expense of a greater negative inotropic action as compared to other cardiodepressant
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molecules (e.g. ACh), which reinforces their therapeutic value and safety in arrhythmias
reversion, in particular those originated in supraventricular tissues.
Figure 21. General mechanistic scheme for the chronoselectivity of ADO. In upper panel (A) is depicted a tubular system of
an atrial myocyte and some of the molecular elements involved in its E-C coupling under basal conditions. Voltage-
dependent activation of CaV1(L) allows Ca2+ entry (ICa,L) into myoplasm that triggers RyR and leads to massive Ca2+ release
from SR. [Ca2+]i transient initiates a rapid contraction of atrial myocytes. Control of Ca2+ current carried by CaV1(L) can occur
through a variety of mechanism, including SK/KCa2 channels activation that reacts against calcium influx. In lower panels are
represented two situations: atrial myocytes exposed to ACh (B) and ADO (C). The potent negative inotropic effect of ACh is
based on activation of M2R and subsequent K+ efflux through GIRK/KIR3 channel opening. Since this hyperpolarizing K+
current shortens the repolarization phase of the AP, M2R decrease the time available for calcium influx (ICa,L) leading to a
reduction in atrial muscle contraction (B). Similar to M2R, A1R also elicits a negative inotropy through Gβγ-mediated
GIRK/KIR3 channel opening. However, A1R stimulates the activity of phospholipase C (PLC) that, in turn, stimulate
breakdown of GIRK/KIR3 channel activator PIP2. Therefore, following stimulation of GIRK carried currents A1R inhibits
GIRK/KIR3 channels by depleting PIP2 in the sarcolemma. Impairment of GIRK/KIR3 channel function by A1R activation
yields a lesser reduction of Ca2+ influx during E-C coupling, which is further potentiated by SK/KCa2 channel inhibition.
Positive inotropic mechanisms may also occur during A1R stimulation such as IP3-induced SR Ca2+ release (via PIP2
breakdown) and further balance of the negative inotropic effect of GIRK/KIR3 channel. Besides IP3, PIP2 hydrolysis also
generate PKC-activator messenger, diacylglicerol (DAG). In summary, when compared to M2R, A1R exhibits an attenuated
GIRK/KIR3-mediated contractile suppression that involves inhibition of SK/KCa2 channel and activation of PLC, explaining
why A1R acts as chronoselective atrial depressant effector. Solid lines represent AP, [Ca2+]I and contraction profile under
basal conditions, whereas dashed lines represent the same parameters when either cholinergic or adenosinergic agonist
are present.
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